This is a table of named entities, their types, and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel. Please keep in mind that named-entity extraction is not as accurate as more generic parts-of-speech extraction. Unusual results will appear here.
| entity | type | frequency |
|---|---|---|
| covid | ORG | 893 |
| sars | DISEASE | 529 |
| virus | TAXON | 419 |
| covid 19 | ORG | 402 |
| infection | DISEASE | 373 |
| sars cov 2 | ORG | 373 |
| viral | TAXON | 338 |
| coronavirus | TAXON | 241 |
| cov | CHEMICAL | 220 |
| human | TAXON | 179 |
| inflammation | DISEASE | 177 |
| ptx | GPE | 126 |
| china | GPE | 116 |
| tnf | ORG | 115 |
| viruses | TAXON | 104 |
| angiotensin | CHEMICAL | 102 |
| coronavirus | TAXON | 101 |
| sars cov | ORG | 101 |
| nac | ORG | 99 |
| vitamin e | ORG | 88 |
| hcq | GPE | 85 |
| individuals | TAXON | 82 |
| atp | ORG | 82 |
| pneumonia | DISEASE | 81 |
| nad | ORG | 78 |
| oxygen | CHEMICAL | 77 |
| wuhan | GPE | 76 |
| ards | ORG | 73 |
| infections | DISEASE | 72 |
| death | DISEASE | 71 |
| il | ORG | 71 |
| vitamin e acetate | PERSON | 69 |
| thrombosis | DISEASE | 66 |
| mice | TAXON | 64 |
| cholesterol | CHEMICAL | 61 |
| coronavirus disease | DISEASE | 57 |
| deaths | DISEASE | 55 |
| humans | TAXON | 53 |
| aat | ORG | 52 |
| obesity | DISEASE | 51 |
| lung injury | DISEASE | 49 |
| respiratory distress syndrome | DISEASE | 48 |
| cd33 | GPE | 47 |
| italy | GPE | 46 |
| coronavirus disease | DISEASE | 46 |
| vitamin | PERSON | 43 |
| ps | ORG | 42 |
| cu | PERSON | 41 |
| angiotensin | CHEMICAL | 41 |
| viral infection | DISEASE | 40 |
| diabetes | DISEASE | 39 |
| rna | ORG | 39 |
| tmv | TAXON | 38 |
| testosterone | CHEMICAL | 38 |
| nitric oxide | CHEMICAL | 37 |
| sepsis | DISEASE | 37 |
| hiv | TAXON | 36 |
| mers | DISEASE | 35 |
| vitamin k | CHEMICAL | 34 |
| viral infections | DISEASE | 34 |
| bacterial | TAXON | 33 |
| fibrosis | DISEASE | 32 |
| neutrophil | GPE | 32 |
| ncov | ORG | 32 |
| cancer | DISEASE | 31 |
| no | CHEMICAL | 31 |
| bcg | ORG | 31 |
| ibuprofen | CHEMICAL | 30 |
| hypoxia | DISEASE | 30 |
| ifn | ORG | 30 |
| critically ill | DISEASE | 29 |
| rats | TAXON | 29 |
| animal | TAXON | 27 |
| glutathione | CHEMICAL | 26 |
| burnout | DISEASE | 26 |
| ppar | ORG | 26 |
| ii | ORG | 26 |
| dha | CHEMICAL | 26 |
| cardiovascular disease | DISEASE | 25 |
| pentoxifylline | PERSON | 25 |
| hydrogen peroxide | CHEMICAL | 25 |
| mouse | TAXON | 25 |
| statins | CHEMICAL | 25 |
| lipopolysaccharide | CHEMICAL | 24 |
| acute lung injury | DISEASE | 24 |
| virus | TAXON | 24 |
| abo | ORG | 24 |
| pg | CHEMICAL | 23 |
| east asia | LOC | 23 |
| human | TAXON | 23 |
| malaria | DISEASE | 23 |
| rbd | ORG | 23 |
| endothelial dysfunction | DISEASE | 23 |
| superoxide | CHEMICAL | 22 |
| rhein | CHEMICAL | 22 |
| murine | TAXON | 22 |
| hypertension | DISEASE | 22 |
| chloramine | CHEMICAL | 22 |
| angiotensin ii | CHEMICAL | 22 |
| oscc | ORG | 22 |
| evali | ORG | 22 |
| k | CHEMICAL | 21 |
| germany | GPE | 21 |
| europe | LOC | 21 |
| adenosine | CHEMICAL | 21 |
| rat | TAXON | 21 |
| viral | TAXON | 20 |
| ang ii | PERSON | 20 |
| dip | CHEMICAL | 20 |
| mycobacterium | TAXON | 20 |
| tumor necrosis | DISEASE | 20 |
| chloroquine | CHEMICAL | 20 |
| respiratory syndrome | DISEASE | 20 |
| tumor | DISEASE | 20 |
| hypoxemia | DISEASE | 20 |
| thrombotic | DISEASE | 19 |
| infectious diseases | DISEASE | 19 |
| host | TAXON | 19 |
| glucose | CHEMICAL | 19 |
| fever | DISEASE | 19 |
| valproic acid | CHEMICAL | 18 |
| camp | CHEMICAL | 18 |
| hydroxychloroquine | CHEMICAL | 18 |
| diabetic | DISEASE | 18 |
| vitamin d | CHEMICAL | 18 |
| vivo | GPE | 18 |
| vascular thrombosis | DISEASE | 18 |
| vitamin | CHEMICAL | 17 |
| tocopherol | CHEMICAL | 17 |
| smoking | CHEMICAL | 17 |
| glioma | GPE | 17 |
| uk | GPE | 17 |
| tb | ORG | 17 |
| montelukast | CHEMICAL | 16 |
| infectious | DISEASE | 16 |
| bradykinin | CHEMICAL | 16 |
| asthma | DISEASE | 16 |
| annexin v | CHEMICAL | 16 |
| treg | GPE | 16 |
| hong kong | GPE | 15 |
| tocilizumab | PERSON | 15 |
| nadph | CHEMICAL | 15 |
| n | ORG | 15 |
| bacteria | TAXON | 15 |
| lung inflammation | DISEASE | 15 |
| cysteine | CHEMICAL | 15 |
| coronavirus pneumonia | DISEASE | 15 |
| pneumonia | DISEASE | 14 |
| cd8 | ORG | 14 |
| covid 19 | ORG | 14 |
| emmprin | PERSON | 14 |
| hydroxychloroquine | CHEMICAL | 14 |
| ibuprofen | GPE | 14 |
| ne | GPE | 14 |
| ace | ORG | 14 |
| zn | CHEMICAL | 14 |
| eclampsia | DISEASE | 14 |
| respiratory syndrome coronavirus 2 sars | DISEASE | 14 |
| sialic acid | CHEMICAL | 14 |
| vitro | GPE | 14 |
| zinc | CHEMICAL | 14 |
| diabetes mellitus | DISEASE | 14 |
| burnout syndrome | DISEASE | 13 |
| jak | ORG | 13 |
| mers cov | ORG | 13 |
| pxr | ORG | 13 |
| sgp | ORG | 13 |
| charcoal | CHEMICAL | 13 |
| pentoxifylline | CHEMICAL | 13 |
| rheumatoid arthritis | DISEASE | 13 |
| toxicity | DISEASE | 13 |
| peep | ORG | 12 |
| allium | PERSON | 12 |
| cd4 | GPE | 12 |
| central europe | LOC | 12 |
| coronavirus disease | DISEASE | 12 |
| curcumin | CHEMICAL | 12 |
| inflammation | DISEASE | 12 |
| li | CHEMICAL | 12 |
| lps | ORG | 12 |
| tf | ORG | 12 |
| type 2 diabetes | DISEASE | 12 |
| acute respiratory distress syndrome | DISEASE | 12 |
| acute respiratory syndrome coronavirus 2 sars cov | DISEASE | 12 |
| bat | TAXON | 12 |
| copper | CHEMICAL | 12 |
| human coronavirus | TAXON | 12 |
| iron | CHEMICAL | 12 |
| thc | ORG | 12 |
| montelukast | CHEMICAL | 11 |
| spain | GPE | 11 |
| sars cov infection | DISEASE | 11 |
| sars cov 1 | ORG | 11 |
| nih | ORG | 11 |
| asia | LOC | 11 |
| dengue | DISEASE | 11 |
| cq | CHEMICAL | 11 |
| copd | ORG | 11 |
| bosentan | ORG | 11 |
| ali | ORG | 11 |
| vitamin k | PERSON | 11 |
| acute respiratory syndrome sars | DISEASE | 11 |
| blood coagulation | DISEASE | 11 |
| statin | CHEMICAL | 11 |
| vitamin e | CHEMICAL | 11 |
| chloramine t | CHEMICAL | 11 |
| tocilizumab | CHEMICAL | 11 |
| the united states | GPE | 11 |
| virus infection | DISEASE | 11 |
| septic shock | DISEASE | 11 |
| respiratory diseases | DISEASE | 11 |
| infectious disease | DISEASE | 11 |
| critically ill covid | DISEASE | 11 |
| conjunctivitis | DISEASE | 11 |
| covid 19 infection | DISEASE | 10 |
| fh dm2 | DISEASE | 10 |
| h1n1 | GPE | 10 |
| acute respiratory syndrome | DISEASE | 10 |
| sicily | GPE | 10 |
| thrombosis | DISEASE | 10 |
| vitamin d | PERSON | 10 |
| acetylcysteine | CHEMICAL | 10 |
| lysine | CHEMICAL | 10 |
| azithromycin | CHEMICAL | 10 |
| estrogen | ORG | 10 |
| influenza | ORG | 10 |
| methionine | CHEMICAL | 10 |
| pulmonary edema | DISEASE | 10 |
| sodium | CHEMICAL | 10 |
| coronavirus infections | DISEASE | 10 |
| vap | ORG | 9 |
| statins | ORG | 9 |
| toronto | GPE | 9 |
| us | GPE | 9 |
| animals | TAXON | 9 |
| who | ORG | 9 |
| alveolar damage | DISEASE | 9 |
| malaria | TAXON | 9 |
| annexin | CHEMICAL | 9 |
| neutrophil | GPE | 9 |
| igg | ORG | 9 |
| ltbi | ORG | 9 |
| japan | GPE | 9 |
| atherosclerosis | DISEASE | 9 |
| il 6 | ORG | 9 |
| dar | ORG | 9 |
| chloroquine | CHEMICAL | 9 |
| ca | CHEMICAL | 9 |
| angiotensin ii | LOC | 9 |
| adenosine | ORG | 9 |
| ace 2 | ORG | 9 |
| arthritis | DISEASE | 9 |
| androgens | CHEMICAL | 9 |
| carcinogenesis | DISEASE | 9 |
| preterm labor | GPE | 9 |
| viral rna | TAXON | 9 |
| tuberculosis | DISEASE | 9 |
| tissue damage | DISEASE | 9 |
| heparin | CHEMICAL | 9 |
| steroid | CHEMICAL | 9 |
| sialoside | CHEMICAL | 9 |
| respiratory syndrome coronavirus | DISEASE | 9 |
| respiratory distress | DISEASE | 9 |
| respiratory disease | DISEASE | 9 |
| rapamycin | CHEMICAL | 9 |
| thrombotic complications | DISEASE | 9 |
| platelet aggregation | DISEASE | 9 |
| melatonin | CHEMICAL | 9 |
| plants | TAXON | 9 |
| hypercapnia | GPE | 9 |
| lung damage | DISEASE | 9 |
| infected | DISEASE | 9 |
| metabolic syndrome | DISEASE | 9 |
| mevalonate | CHEMICAL | 9 |
| monochloramine | CHEMICAL | 9 |
| phosphatidylserine | CHEMICAL | 9 |
| ntd | ORG | 8 |
| angiotensin i | CHEMICAL | 8 |
| vka | CHEMICAL | 8 |
| spike | ORG | 8 |
| serpin | ORG | 8 |
| rh | PERSON | 8 |
| obesity | ORG | 8 |
| cryptococcus | ORG | 8 |
| mice | TAXON | 8 |
| med hypotheses | PERSON | 8 |
| influenza | ORG | 8 |
| hif | ORG | 8 |
| candida | TAXON | 8 |
| coronavirus sars cov | DISEASE | 8 |
| coagulopathy | DISEASE | 8 |
| respiratory failure | DISEASE | 8 |
| cough | DISEASE | 8 |
| liver injury | DISEASE | 8 |
| depression | DISEASE | 8 |
| the world health organization | ORG | 8 |
| selenoproteins | CHEMICAL | 8 |
| phosphatidylglycerol | CHEMICAL | 8 |
| myocardial infarction | DISEASE | 8 |
| venous thromboembolism | DISEASE | 8 |
| hypertension diabetes | DISEASE | 8 |
| hyperglycemia | DISEASE | 8 |
| humidity | DISEASE | 8 |
| heart failure | DISEASE | 8 |
| glycation | CHEMICAL | 8 |
| garlic extract | CHEMICAL | 8 |
| glutathione | CHEMICAL | 7 |
| pmn | CHEMICAL | 7 |
| opmds | DISEASE | 7 |
| na | PERSON | 7 |
| mount etna | LOC | 7 |
| monochloramine | PERSON | 7 |
| mas | ORG | 7 |
| hydrogen peroxide | CHEMICAL | 7 |
| hydrogen | ORG | 7 |
| covid19 | ORG | 7 |
| gm | ORG | 7 |
| fenofibrate | PERSON | 7 |
| emodin | PERSON | 7 |
| defensins | ORG | 7 |
| dka | ORG | 7 |
| coronavirus infected pneumonia | DISEASE | 7 |
| plasma | PERSON | 7 |
| ang | PERSON | 7 |
| abh | ORG | 7 |
| ptx dip | ORG | 7 |
| infections | DISEASE | 7 |
| plasmodium | ORG | 7 |
| diarrhea | DISEASE | 7 |
| respiratory distress syndrome | DISEASE | 7 |
| thrombi | DISEASE | 7 |
| pathologies | DISEASE | 7 |
| osteoarthritis | DISEASE | 7 |
| nicotine | CHEMICAL | 7 |
| lymphopenia | DISEASE | 7 |
| herpes simplex | DISEASE | 7 |
| fatigue | DISEASE | 7 |
| endothelial damage | DISEASE | 7 |
| magnesium | CHEMICAL | 7 |
| coronavirus infection | DISEASE | 7 |
| chronic obstructive pulmonary disease | DISEASE | 7 |
| calcium | CHEMICAL | 7 |
| bosentan | GPE | 7 |
| arginine | CHEMICAL | 7 |
| amino acid | CHEMICAL | 7 |
| vegfr | ORG | 7 |
| comorbidity | DISEASE | 7 |
| rhein | PERSON | 7 |
| mesenchymal | GPE | 6 |
| infection | DISEASE | 6 |
| leydig | ORG | 6 |
| lithium | GPE | 6 |
| lung injury | DISEASE | 6 |
| magnesium | LOC | 6 |
| sars cov 2 infection | DISEASE | 6 |
| mt | CHEMICAL | 6 |
| new york city | GPE | 6 |
| nitric | PERSON | 6 |
| sirs | ORG | 6 |
| hypertension | DISEASE | 6 |
| vte | ORG | 6 |
| hypoxia | GPE | 6 |
| bal | ORG | 6 |
| hiv infected | DISEASE | 6 |
| fda | ORG | 6 |
| ees | ORG | 6 |
| diabetes | DISEASE | 6 |
| dd | ORG | 6 |
| damp | ORG | 6 |
| crohn s disease | DISEASE | 6 |
| coronavirus pneumonia | DISEASE | 6 |
| burkholderia cepacia | PERSON | 6 |
| bavaria | GPE | 6 |
| animal | TAXON | 6 |
| amp | CHEMICAL | 6 |
| adp | ORG | 6 |
| bone destruction | DISEASE | 6 |
| vaccine | GPE | 6 |
| fenofibrate | CHEMICAL | 6 |
| bovine | TAXON | 6 |
| mammalian | TAXON | 6 |
| chronic kidney disease | DISEASE | 6 |
| vitamin derivative | CHEMICAL | 6 |
| vitamin d3 | CHEMICAL | 6 |
| virus rna | TAXON | 6 |
| tissue injury | DISEASE | 6 |
| syncytial virus | TAXON | 6 |
| rat hepatocytes | TAXON | 6 |
| pulmonary inflammation | DISEASE | 6 |
| organ dysfunction | DISEASE | 6 |
| nanoparticles | CHEMICAL | 6 |
| multiple organ failure | DISEASE | 6 |
| multiorgan | GPE | 6 |
| microbes | TAXON | 6 |
| respiratory infections | DISEASE | 6 |
| lithium chloride | CHEMICAL | 6 |
| endotheliitis | DISEASE | 6 |
| cortisol | CHEMICAL | 6 |
| ischemia | DISEASE | 6 |
| curcumin | PERSON | 6 |
| diabetic nephropathy | DISEASE | 6 |
| dipyridamole | CHEMICAL | 6 |
| dyspnea | DISEASE | 6 |
| von willebrand | ORG | 6 |
| glucocorticoids | CHEMICAL | 6 |
| hemorrhagic consumptive coagulopathy | DISEASE | 6 |
| histo | DISEASE | 6 |
| hyperinsulinemia | PERSON | 6 |
| il 1 | ORG | 5 |
| qt | ORG | 5 |
| iv | ORG | 5 |
| immune | LOC | 5 |
| mycobacterium tuberculosis | CHEMICAL | 5 |
| n acetylcysteine | CHEMICAL | 5 |
| osmf | ORG | 5 |
| pde | ORG | 5 |
| pseudomonas | GPE | 5 |
| respiratory failure | DISEASE | 5 |
| rnaemia | GPE | 5 |
| viruses | TAXON | 5 |
| respiratory syndrome | DISEASE | 5 |
| sars coronavirus | DISEASE | 5 |
| south korea | GPE | 5 |
| testosterone | CHEMICAL | 5 |
| tregs | ORG | 5 |
| tgf | ORG | 5 |
| azithromycin | CHEMICAL | 5 |
| hcq cq | CHEMICAL | 5 |
| cc | CHEMICAL | 5 |
| acute respiratory syndrome coronavirus | DISEASE | 5 |
| aat deficiency | DISEASE | 5 |
| ace inhibitors | CHEMICAL | 5 |
| ad | DISEASE | 5 |
| ags | CHEMICAL | 5 |
| bame | ORG | 5 |
| bph | ORG | 5 |
| cd4 t | ORG | 5 |
| france | GPE | 5 |
| canada | GPE | 5 |
| chilblains | PERSON | 5 |
| crohn s | PERSON | 5 |
| dbp | ORG | 5 |
| dic | ORG | 5 |
| etna | ORG | 5 |
| fibrosis | DISEASE | 5 |
| yersinia | GPE | 5 |
| leukotrienes | CHEMICAL | 5 |
| albuminuria | GPE | 5 |
| rodent | TAXON | 5 |
| necrotic | DISEASE | 5 |
| neurodegenerative diseases | DISEASE | 5 |
| nitrate | CHEMICAL | 5 |
| opacity | DISEASE | 5 |
| periodontitis | DISEASE | 5 |
| phosphatidylcholine | CHEMICAL | 5 |
| respiratory infection | DISEASE | 5 |
| the mount etna | LOC | 5 |
| lactate | CHEMICAL | 5 |
| the sars cov 2 | ORG | 5 |
| type 2 diabetes mellitus | DISEASE | 5 |
| vascular damage | DISEASE | 5 |
| viral diseases | DISEASE | 5 |
| viral genome | TAXON | 5 |
| viremia | DISEASE | 5 |
| allele | PERSON | 5 |
| liver disease | DISEASE | 5 |
| virus disease | DISEASE | 5 |
| ketonuria | GPE | 5 |
| diacerein | CHEMICAL | 5 |
| immunocompromised | DISEASE | 5 |
| angiotensin aldosterone | CHEMICAL | 5 |
| bacterial infection | DISEASE | 5 |
| bias | CHEMICAL | 5 |
| chronic diseases | DISEASE | 5 |
| conflict | DISEASE | 5 |
| dexamethasone | CHEMICAL | 5 |
| angiotensin 1 9 | CHEMICAL | 5 |
| dogs | TAXON | 5 |
| galactose | CHEMICAL | 5 |
| gastroenteritis | DISEASE | 5 |
| hepatitis b | DISEASE | 5 |
| human cells | TAXON | 5 |
| hypertensive | DISEASE | 5 |
| fungal | TAXON | 5 |
| hypotension | DISEASE | 5 |
| nk | ORG | 4 |
| pparδ | CHEMICAL | 4 |
| pe | ORG | 4 |
| pbs | ORG | 4 |
| opmd | ORG | 4 |
| nitric oxide | CHEMICAL | 4 |
| na k | CHEMICAL | 4 |
| messina | GPE | 4 |
| nhs | ORG | 4 |
| nalp3 | DISEASE | 4 |
| middle east | LOC | 4 |
| medical hypotheses | ORG | 4 |
| mgp | ORG | 4 |
| maf | ORG | 4 |
| lipid | GPE | 4 |
| phosphatidylserine | GPE | 4 |
| lo | PERSON | 4 |
| thromboembolic | ORG | 4 |
| pregnane | CHEMICAL | 4 |
| prevalence | ORG | 4 |
| iκbα | GPE | 4 |
| anthraquinone | CHEMICAL | 4 |
| angiotensin 1 7 | CHEMICAL | 4 |
| allergic rhinitis | DISEASE | 4 |
| adenosine monophosphate | CHEMICAL | 4 |
| xii | ORG | 4 |
| vietnam | GPE | 4 |
| usa | GPE | 4 |
| toronto canada | ORG | 4 |
| tocopherol | CHEMICAL | 4 |
| tcr | CHEMICAL | 4 |
| são paulo | GPE | 4 |
| respiratory syndrome coronavirus 2 sars | DISEASE | 4 |
| respiratory syndrome coronavirus | DISEASE | 4 |
| pulmonary vascular endothelialitis thrombosis | DISEASE | 4 |
| je | ORG | 4 |
| diild | ORG | 4 |
| ivermectin | ORG | 4 |
| cu deficiency | DISEASE | 4 |
| catania | GPE | 4 |
| cyp1a2 | CHEMICAL | 4 |
| ctd | ORG | 4 |
| csf | ORG | 4 |
| cmv | DISEASE | 4 |
| burnout | PERSON | 4 |
| autophagy | PERSON | 4 |
| akt | PERSON | 4 |
| ahr | ORG | 4 |
| aerosol | GPE | 4 |
| abnormal coagulation | DISEASE | 4 |
| azm | ORG | 4 |
| ampk | ORG | 4 |
| ace ii | CHEMICAL | 4 |
| anxiety | DISEASE | 4 |
| cryptococcus neoformans | TAXON | 4 |
| dad | ORG | 4 |
| iga | ORG | 4 |
| dr | DISEASE | 4 |
| il 10 | ORG | 4 |
| hypomagnesemia | ORG | 4 |
| humans | TAXON | 4 |
| hocl | CHEMICAL | 4 |
| hiv infection | DISEASE | 4 |
| hex | ORG | 4 |
| h7n9 | GPE | 4 |
| garlic | ORG | 4 |
| gr | PERSON | 4 |
| ebola virus | TAXON | 4 |
| ebola | TAXON | 4 |
| eg | GPE | 4 |
| ec | ORG | 4 |
| dihydroxyacetone | ORG | 4 |
| death | DISEASE | 4 |
| antitrypsin | CHEMICAL | 4 |
| sec | PERSON | 4 |
| atherosclerotic | DISEASE | 4 |
| oral cancer | DISEASE | 4 |
| preeclampsia | DISEASE | 4 |
| potassium | CHEMICAL | 4 |
| posturing | DISEASE | 4 |
| phosphate | CHEMICAL | 4 |
| overweight | DISEASE | 4 |
| overactive | DISEASE | 4 |
| organism | TAXON | 4 |
| nutritional deficiencies | DISEASE | 4 |
| lung disease | DISEASE | 4 |
| neuroblastoma | DISEASE | 4 |
| myopathy | DISEASE | 4 |
| multiorgan failure | DISEASE | 4 |
| multi organ failure | DISEASE | 4 |
| microbiome | TAXON | 4 |
| metabolic disorders | DISEASE | 4 |
| malaria infection | DISEASE | 4 |
| pulmonary sarcoidosis | DISEASE | 4 |
| rabbit | TAXON | 4 |
| rabbits | TAXON | 4 |
| respiratory disorders | DISEASE | 4 |
| vitamin k insufficiency | CHEMICAL | 4 |
| viral upper respiratory tract infections | DISEASE | 4 |
| viral proteins | TAXON | 4 |
| viral protein fragment | TAXON | 4 |
| tyrosine | CHEMICAL | 4 |
| turpentine | CHEMICAL | 4 |
| thromboembolism | DISEASE | 4 |
| the food and drug administration | ORG | 4 |
| taurine chloramine | CHEMICAL | 4 |
| surfactant dysfunction | DISEASE | 4 |
| sulfatide | CHEMICAL | 4 |
| steroids | CHEMICAL | 4 |
| squamous cell carcinoma | DISEASE | 4 |
| shock | DISEASE | 4 |
| respiratory illness | DISEASE | 4 |
| lung infection | DISEASE | 4 |
| stroke | DISEASE | 4 |
| lung cancer | DISEASE | 4 |
| esterified | CHEMICAL | 4 |
| endotoxemia | DISEASE | 4 |
| endothelial injury | DISEASE | 4 |
| birds | TAXON | 4 |
| doxycycline | CHEMICAL | 4 |
| diacylglycerol | CHEMICAL | 4 |
| cystine | CHEMICAL | 4 |
| cysteinyl leukotriene | CHEMICAL | 4 |
| crystalline | CHEMICAL | 4 |
| coronavirus infected pneumonia | DISEASE | 4 |
| cancer a | DISEASE | 4 |
| calprotectin | CHEMICAL | 4 |
| budesonide | CHEMICAL | 4 |
| bronchiectasis | DISEASE | 4 |
| blood clotting | DISEASE | 4 |
| lopinavir ritonavir | PERSON | 4 |
| eosinophilia | DISEASE | 4 |
| chlorine | CHEMICAL | 4 |
| fatalities | DISEASE | 4 |
| hypothermia | DISEASE | 4 |
| leukotriene | CHEMICAL | 4 |
| fatty acid | CHEMICAL | 4 |
| injurious pulmonary inflammatory | DISEASE | 4 |
| influenza virus infection | DISEASE | 4 |
| influenza infections | DISEASE | 4 |
| indoxyl sulfate | PERSON | 4 |
| illness | DISEASE | 4 |
| infectious conjunctivitis | DISEASE | 4 |
| hyperinflammation | DISEASE | 4 |
| human immunodeficiency virus hiv | DISEASE | 4 |
| fatty acids | CHEMICAL | 4 |
| hosts | TAXON | 4 |
| hemorrhagic shock | DISEASE | 4 |
| hydroxychloroquine hcq | CHEMICAL | 4 |
| fulminant acute respiratory distress syndrome | DISEASE | 4 |
| sars cov 2 | ORG | 3 |
| raa | ORG | 3 |
| rapamycin | GPE | 3 |
| respiratory syndrome sars | DISEASE | 3 |
| ritonavir | CHEMICAL | 3 |
| sars cov | ORG | 3 |
| sars cov 2 sgp | ORG | 3 |
| siglec 5 | GPE | 3 |
| simvastatin | CHEMICAL | 3 |
| pseudomona aeruginosa | ORG | 3 |
| sildenafil | CHEMICAL | 3 |
| pulmunary diseases | DISEASE | 3 |
| melatonin | ORG | 3 |
| plasmodium falciparum | TAXON | 3 |
| pgc 1α | CHEMICAL | 3 |
| outcomes | ORG | 3 |
| ocular | ORG | 3 |
| nadp | ORG | 3 |
| n acetylcysteine nac | ORG | 3 |
| mycoplasma | ORG | 3 |
| mechanisms | GPE | 3 |
| lithium chloride | CHEMICAL | 3 |
| lisofylline | PERSON | 3 |
| single | ORG | 3 |
| lessons | ORG | 3 |
| singapore | GPE | 3 |
| alpha n | ORG | 3 |
| studies | ORG | 3 |
| tlr | ORG | 3 |
| latin america | LOC | 3 |
| bipolar disorder | DISEASE | 3 |
| bioaerosol | DISEASE | 3 |
| avian | TAXON | 3 |
| angiotensin converting | PERSON | 3 |
| ammonia | CHEMICAL | 3 |
| amino acids | CHEMICAL | 3 |
| ambroxol | CHEMICAL | 3 |
| alpha 1 antitrypsin | CHEMICAL | 3 |
| adiponectin | CHEMICAL | 3 |
| acute respiratory syndrome coronavirus infection | DISEASE | 3 |
| acetylcholine | CHEMICAL | 3 |
| zika | GPE | 3 |
| yellow fever | DISEASE | 3 |
| yellow | PERSON | 3 |
| vitro | PERSON | 3 |
| vitamin e acetate | PERSON | 3 |
| vitamin d3 | CHEMICAL | 3 |
| vero e6 | ORG | 3 |
| valsartan | LOC | 3 |
| va | ORG | 3 |
| taurine chloramine | CHEMICAL | 3 |
| tmv virions | TAXON | 3 |
| leptin | PERSON | 3 |
| cdc | ORG | 3 |
| janaína | ORG | 3 |
| cpg | ORG | 3 |
| chronic | ORG | 3 |
| chloramine | GPE | 3 |
| chen | PERSON | 3 |
| cardiovascular disease | DISEASE | 3 |
| cancer | DISEASE | 3 |
| crs | DISEASE | 3 |
| ci | ORG | 3 |
| bone lesions | DISEASE | 3 |
| cd8 t | ORG | 3 |
| brazil | GPE | 3 |
| beijing | GPE | 3 |
| annexin | CHEMICAL | 3 |
| angii | CHEMICAL | 3 |
| ang 1 7 | PERSON | 3 |
| aminoglycosides | LOC | 3 |
| allicin | CHEMICAL | 3 |
| acute | PERSON | 3 |
| atii | ORG | 3 |
| aids | DISEASE | 3 |
| aecii | ORG | 3 |
| ace ang ii | CHEMICAL | 3 |
| ace 2 expression | CHEMICAL | 3 |
| abg | ORG | 3 |
| coagulopathy | PERSON | 3 |
| dag | ORG | 3 |
| interferon | ORG | 3 |
| defa | ORG | 3 |
| innate | ORG | 3 |
| individuals | TAXON | 3 |
| il 2 | ORG | 3 |
| hanoi | GPE | 3 |
| hla | ORG | 3 |
| hbv | ORG | 3 |
| h5n1 | TAXON | 3 |
| glucose | CHEMICAL | 3 |
| genomic | ORG | 3 |
| gsh | CHEMICAL | 3 |
| gbs | ORG | 3 |
| g csf | ORG | 3 |
| exosurf | PERSON | 3 |
| epstein barr | PERSON | 3 |
| epidemiological | ORG | 3 |
| endotheliopathy | DISEASE | 3 |
| east | LOC | 3 |
| elp | ORG | 3 |
| egfr | ORG | 3 |
| ecmo | ORG | 3 |
| dipyridamole | PERSON | 3 |
| diabetic | DISEASE | 3 |
| dht | CHEMICAL | 3 |
| bleeding | DISEASE | 3 |
| respiratory infections | DISEASE | 3 |
| bone loss | DISEASE | 3 |
| protozoan | TAXON | 3 |
| respiratory virus | TAXON | 3 |
| respiratory viral infections | DISEASE | 3 |
| respiratory viral infection | DISEASE | 3 |
| respiratory system damage | DISEASE | 3 |
| respiratory syndrome coronavirus sars | DISEASE | 3 |
| respiratory disorder | DISEASE | 3 |
| renal dysfunction | DISEASE | 3 |
| quercetin | CHEMICAL | 3 |
| pulmonary ossification | DISEASE | 3 |
| pulmonary hypertension | DISEASE | 3 |
| pulmonary complications | DISEASE | 3 |
| prostatitis | DISEASE | 3 |
| saturated phosphatidylcholine | CHEMICAL | 3 |
| prostate cancer | DISEASE | 3 |
| poliovirus | TAXON | 3 |
| peroxide | CHEMICAL | 3 |
| pentoxifylline ptx | CHEMICAL | 3 |
| oseltamivir | CHEMICAL | 3 |
| organisms | TAXON | 3 |
| organ failure | DISEASE | 3 |
| oedema | DISEASE | 3 |
| nucleic acid | CHEMICAL | 3 |
| nitrite | CHEMICAL | 3 |
| nicotinamide adenine dinucleotide nad | CHEMICAL | 3 |
| resveratrol | CHEMICAL | 3 |
| selenium | CHEMICAL | 3 |
| multiorgan damage | DISEASE | 3 |
| vascular disease | DISEASE | 3 |
| bone marrow suppression | DISEASE | 3 |
| Δ32 | CHEMICAL | 3 |
| water loss | DISEASE | 3 |
| vitamin k2 | CHEMICAL | 3 |
| vitamin k epoxide | CHEMICAL | 3 |
| virally | TAXON | 3 |
| viral pneumonia | DISEASE | 3 |
| viral envelope | TAXON | 3 |
| viraemia | DISEASE | 3 |
| vascular injury | DISEASE | 3 |
| vascular endothelial dysfunction | DISEASE | 3 |
| tuberculosis infection | DISEASE | 3 |
| shortness of breath | DISEASE | 3 |
| triglyceride | CHEMICAL | 3 |
| trauma | DISEASE | 3 |
| thrombus | DISEASE | 3 |
| thrombocytopenia | DISEASE | 3 |
| the middle east | LOC | 3 |
| tears | DISEASE | 3 |
| swine | TAXON | 3 |
| sulfur dioxide | CHEMICAL | 3 |
| sulfate | CHEMICAL | 3 |
| south west | LOC | 3 |
| simvastatin | CHEMICAL | 3 |
| necrosis | DISEASE | 3 |
| taurine | CHEMICAL | 3 |
| multi organ dysfunction | DISEASE | 3 |
| coronavirus sars | DISEASE | 3 |
| hypercoagulability | DISEASE | 3 |
| human hepatocytes | TAXON | 3 |
| human body | TAXON | 3 |
| host cells | TAXON | 3 |
| glycine | CHEMICAL | 3 |
| gastrointestinal symptoms | DISEASE | 3 |
| fish | TAXON | 3 |
| endotoxic | GPE | 3 |
| encephalitis | DISEASE | 3 |
| earth pneumoconiosis | DISEASE | 3 |
| dihydroxyacetone | CHEMICAL | 3 |
| coronavirus nl63 | DISEASE | 3 |
| immune dysfunction | DISEASE | 3 |
| coronavirus covid | DISEASE | 3 |
| coronary heart disease | DISEASE | 3 |
| cord_uid | ORG | 3 |
| convalescent | DISEASE | 3 |
| coagulation abnormalities | DISEASE | 3 |
| chloramines | CHEMICAL | 3 |
| cardiac injury | DISEASE | 3 |
| cardiac disease | DISEASE | 3 |
| carbon monoxide | CHEMICAL | 3 |
| minimise disease | DISEASE | 3 |
| carbohydrates | CHEMICAL | 3 |
| hypercoagulopathy | DISEASE | 3 |
| coronavirus 2019 2019 ncov uses | DISEASE | 3 |
| impaired renal function | DISEASE | 3 |
| lipids | CHEMICAL | 3 |
| microvascular thrombosis | DISEASE | 3 |
| microvascular injury | DISEASE | 3 |
| indomethacin | CHEMICAL | 3 |
| microvascular | ORG | 3 |
| methacholine | CHEMICAL | 3 |
| man | TAXON | 3 |
| mammals | TAXON | 3 |
| macrolide | CHEMICAL | 3 |
| luminal | CHEMICAL | 3 |
| lopinavir | CHEMICAL | 3 |
| lithium | CHEMICAL | 3 |
| macrolides | CHEMICAL | 3 |
| leptin | PERSON | 3 |
| intravascular coagulation | DISEASE | 3 |
| lactose | CHEMICAL | 3 |
| influenza infection | DISEASE | 3 |
| interferon gamma | CHEMICAL | 3 |
| intracranial infections | DISEASE | 3 |
| inflammatory diseases | DISEASE | 3 |
| ketoacidosis | DISEASE | 3 |
| kidney disease | DISEASE | 3 |
| interferon | ORG | 3 |
| oa | ORG | 2 |
| neopterin | GPE | 2 |
| north america | LOC | 2 |
| north | GPE | 2 |
| opv | ORG | 2 |
| nitric oxide | CHEMICAL | 2 |
| new orleans | GPE | 2 |
| nanjing | GPE | 2 |
| ndesethylchloroquine | ORG | 2 |
| nasal | PERSON | 2 |
| nacetylcysteine | PERSON | 2 |
| nacl | CHEMICAL | 2 |
| nadh | ORG | 2 |
| oral nac | ORG | 2 |
| net | ORG | 2 |
| nfkb | ORG | 2 |
| oleic acid | ORG | 2 |
| park | PERSON | 2 |
| osaka university | ORG | 2 |
| outcome | ORG | 2 |
| prognosis | ORG | 2 |
| prostate cancer | DISEASE | 2 |
| n chlorotaurine | CHEMICAL | 2 |
| prof greenhalgh | PERSON | 2 |
| primary symptoms comorbidities | ORG | 2 |
| poliovirus | TAXON | 2 |
| plasmodium falciparum malaria | DISEASE | 2 |
| pathogenic | ORG | 2 |
| phb | ORG | 2 |
| pge2 | ORG | 2 |
| pdt | CHEMICAL | 2 |
| pcr | ORG | 2 |
| pamp | ORG | 2 |
| pai 1 | ORG | 2 |
| oxygen | CHEMICAL | 2 |
| n95 | ORG | 2 |
| met | CHEMICAL | 2 |
| n acetyl cysteine | CHEMICAL | 2 |
| n acetylcysteine | PERSON | 2 |
| maillard | PERSON | 2 |
| macrolides | CHEMICAL | 2 |
| msc | ORG | 2 |
| mip | ORG | 2 |
| mers coronavirus infection | DISEASE | 2 |
| mers cov sars cov 2 | ORG | 2 |
| mct | CHEMICAL | 2 |
| mbi | ORG | 2 |
| mamps | ORG | 2 |
| luminex | ORG | 2 |
| lopinavir | PERSON | 2 |
| lombardy | GPE | 2 |
| liver injury | DISEASE | 2 |
| pseudomonas aeruginosa | DISEASE | 2 |
| listeria | TAXON | 2 |
| mammalian sirt1 | TAXON | 2 |
| marburg | GPE | 2 |
| marburg virus | TAXON | 2 |
| mmacrolides | ORG | 2 |
| murine | TAXON | 2 |
| mt etna | PERSON | 2 |
| mouse | TAXON | 2 |
| mortality | DISEASE | 2 |
| monocyte | GPE | 2 |
| molecular | ORG | 2 |
| mitochondria | GPE | 2 |
| masayuki miyasaka | PERSON | 2 |
| microvascular | GPE | 2 |
| mevalonate | CHEMICAL | 2 |
| meta | ORG | 2 |
| meplazumab | CHEMICAL | 2 |
| mediterranean | LOC | 2 |
| maternal | ORG | 2 |
| pseudomonas ards | DISEASE | 2 |
| tmprss2 | GPE | 2 |
| pubmed | GPE | 2 |
| trialstracker | ORG | 2 |
| tni | ORG | 2 |
| thrombotic | DISEASE | 2 |
| theophylline | PERSON | 2 |
| tears | ORG | 2 |
| taurine | ORG | 2 |
| tau cl | PERSON | 2 |
| taiwan | GPE | 2 |
| trt | ORG | 2 |
| tnfalpha | ORG | 2 |
| tim | ORG | 2 |
| thccontaining | ORG | 2 |
| tb infections | DISEASE | 2 |
| sweden | GPE | 2 |
| sub saharan africa | LOC | 2 |
| steim | ORG | 2 |
| transmembrane | ORG | 2 |
| tumor necrosis | DISEASE | 2 |
| rnaaemia | ORG | 2 |
| u | CHEMICAL | 2 |
| leishmaniasis | GPE | 2 |
| xi | PERSON | 2 |
| wuhan city | GPE | 2 |
| yang | PERSON | 2 |
| wu | PERSON | 2 |
| world health organization | ORG | 2 |
| wilson | PERSON | 2 |
| walmrath | PERSON | 2 |
| wt | ORG | 2 |
| von willebrand | PERSON | 2 |
| vitamin e succinate | ORG | 2 |
| virus copper | TAXON | 2 |
| vero | ORG | 2 |
| vsv | ORG | 2 |
| united kingdom | GPE | 2 |
| statin | CHEMICAL | 2 |
| staphylococcus | LOC | 2 |
| spike s | PERSON | 2 |
| south east asia | LOC | 2 |
| sars cov 2 cell entry depends | ORG | 2 |
| sars cov 2 covid 19 | ORG | 2 |
| sara cov 2 | ORG | 2 |
| sara cov | CHEMICAL | 2 |
| sar cov 2 | ORG | 2 |
| rutin | PERSON | 2 |
| robert miller | PERSON | 2 |
| rheum | ORG | 2 |
| rhesus | TAXON | 2 |
| resveratrol | PERSON | 2 |
| respiratory syndrome coronavirus 2 sars cov | DISEASE | 2 |
| recognition | ORG | 2 |
| rats | TAXON | 2 |
| rat | TAXON | 2 |
| rapid | PERSON | 2 |
| sars cov 2 testosterone | ORG | 2 |
| sars cov 2 date 2020 | ORG | 2 |
| sars cov infected | DISEASE | 2 |
| selenoprotein | PERSON | 2 |
| solanaceae | LOC | 2 |
| smoking | CHEMICAL | 2 |
| singlet | ORG | 2 |
| siglecs | ORG | 2 |
| severe acute respiratory syndrome | ORG | 2 |
| selenoproteins | PERSON | 2 |
| selective | ORG | 2 |
| sars cov 2 disease | DISEASE | 2 |
| stat | ORG | 2 |
| sle | DISEASE | 2 |
| sic | ORG | 2 |
| sda | ORG | 2 |
| sars corona virus 2 infection | DISEASE | 2 |
| sars mers | DISEASE | 2 |
| leucine | ORG | 2 |
| a32740 | PERSON | 2 |
| lancet | ORG | 2 |
| conjunctivitis | PERSON | 2 |
| clinical characteristics | ORG | 2 |
| citrobacter rodentium infection | DISEASE | 2 |
| chrysophanol | PERSON | 2 |
| chronic pulmonary disease | DISEASE | 2 |
| cholesterol | CHEMICAL | 2 |
| calmette | CHEMICAL | 2 |
| ct mri department | ORG | 2 |
| crp | ORG | 2 |
| covid 19 neutrophil | ORG | 2 |
| covid 19 immune | ORG | 2 |
| cmv pneumonia | DISEASE | 2 |
| cd4 cd25 foxp3 treg | ORG | 2 |
| bronchoscopic | GPE | 2 |
| bradykinin | CHEMICAL | 2 |
| bone | ORG | 2 |
| clinicaltrials | ORG | 2 |
| convalescent | DISEASE | 2 |
| dm | DISEASE | 2 |
| coronavirus disease19 | CHEMICAL | 2 |
| cysteinyl | ORG | 2 |
| cyclic nucleotide | CHEMICAL | 2 |
| curosurf | PERSON | 2 |
| cu oxide | CHEMICAL | 2 |
| cu 2 ions | CHEMICAL | 2 |
| creatine | CHEMICAL | 2 |
| covid 192020 | ORG | 2 |
| covid 19 disease | DISEASE | 2 |
| coulombic | CHEMICAL | 2 |
| coronavirus nl63 | TAXON | 2 |
| coronavirus infections | DISEASE | 2 |
| coronavirus covid | DISEASE | 2 |
| coronavirus 2019 covid | DISEASE | 2 |
| coronavirus 2 sars cov | ORG | 2 |
| coronavirus disease19 covid19 | ORG | 2 |
| bmal1 | GPE | 2 |
| blood | ORG | 2 |
| blocked | PERSON | 2 |
| bilirubin | PERSON | 2 |
| allium sativum garlic | CHEMICAL | 2 |
| alliin | GPE | 2 |
| akt mapk | PERSON | 2 |
| airborne | ORG | 2 |
| ag ii | CHEMICAL | 2 |
| africa | LOC | 2 |
| aazithromycin | GPE | 2 |
| aandrographolides | PERSON | 2 |
| aaminoglycosides | ORG | 2 |
| atr | ORG | 2 |
| acei | ORG | 2 |
| ab | ORG | 2 |
| a20 | ORG | 2 |
| 5ht | CHEMICAL | 2 |
| yours | ORG | 2 |
| alzheimer s disease | DISEASE | 2 |
| amino acid | CHEMICAL | 2 |
| ang 1 | ORG | 2 |
| bd biosciences | ORG | 2 |
| berlin | GPE | 2 |
| bergamo | GPE | 2 |
| beclin1 | PERSON | 2 |
| barr virus | TAXON | 2 |
| bakhit | GPE | 2 |
| bactericidal | PERSON | 2 |
| basigin | ORG | 2 |
| angi | ORG | 2 |
| australia | GPE | 2 |
| antitrypsin | CHEMICAL | 2 |
| antiphospholipid | DISEASE | 2 |
| annexin v | PERSON | 2 |
| angiotensin converting enzyme ii | ORG | 2 |
| angiotensin aldosterone | CHEMICAL | 2 |
| dab | GPE | 2 |
| dm2 | DISEASE | 2 |
| ltbis | CHEMICAL | 2 |
| iga deficiency | DISEASE | 2 |
| iso | ORG | 2 |
| iqr | ORG | 2 |
| il 1 and | ORG | 2 |
| iii | ORG | 2 |
| ifn gamma | CHEMICAL | 2 |
| ifn 1 | ORG | 2 |
| hypogonadism | DISEASE | 2 |
| hydrocortisone | CHEMICAL | 2 |
| hubei | GPE | 2 |
| huang | PERSON | 2 |
| hoque | GPE | 2 |
| herpes simplex virus hsv | TAXON | 2 |
| herein | ORG | 2 |
| hepcidin | PERSON | 2 |
| hapivirins | PERSON | 2 |
| iv nac | ORG | 2 |
| immunotherapy | ORG | 2 |
| deaths | DISEASE | 2 |
| india | GPE | 2 |
| ldls | CHEMICAL | 2 |
| kuebler | PERSON | 2 |
| klompas baker | PERSON | 2 |
| kinetics | PERSON | 2 |
| kappa bioscience as | ORG | 2 |
| kda | ORG | 2 |
| junin | PERSON | 2 |
| jun | PERSON | 2 |
| journal | ORG | 2 |
| janus | GPE | 2 |
| jw | ORG | 2 |
| jak stat | ORG | 2 |
| italy cryptococcus | ORG | 2 |
| intracellular | ORG | 2 |
| infasurf | ORG | 2 |
| hantoushzadeh | CHEMICAL | 2 |
| hcov nl63 | DISEASE | 2 |
| hba1cs | ORG | 2 |
| h3n2 | GPE | 2 |
| el | DISEASE | 2 |
| efb | ORG | 2 |
| edanz group | ORG | 2 |
| ebola s consumptive coagulopathy | DISEASE | 2 |
| eastern asia | LOC | 2 |
| early transmission dynamics | ORG | 2 |
| emmprin basigin | PERSON | 2 |
| egcg | CHEMICAL | 2 |
| duffy | ORG | 2 |
| down | DISEASE | 2 |
| discov vitamin d | PERSON | 2 |
| dihydroxyacetone dha | CHEMICAL | 2 |
| dietary | PERSON | 2 |
| diacylglycerol | CHEMICAL | 2 |
| dexamethasone | CHEMICAL | 2 |
| estrogen | ORG | 2 |
| fad | ORG | 2 |
| fao | ORG | 2 |
| gabrin | PERSON | 2 |
| gut | PERSON | 2 |
| guangdong | GPE | 2 |
| glycyrrhizin | PERSON | 2 |
| glycerite | PERSON | 2 |
| genetics | PERSON | 2 |
| gastrointestinal bleeding | ORG | 2 |
| gpi | ORG | 2 |
| fahrenkopf | GPE | 2 |
| g | ORG | 2 |
| formaldehyde | PERSON | 2 |
| flu | TAXON | 2 |
| fiji image | ORG | 2 |
| fio | CHEMICAL | 2 |
| fang | PERSON | 2 |
| yasin | ORG | 2 |
| thujaplicin cu | PERSON | 2 |
| zika virus | TAXON | 2 |
| periodontal disease | DISEASE | 2 |
| pathogen | ORG | 2 |
| panic | DISEASE | 2 |
| pandemic disease | DISEASE | 2 |
| pandemia | DISEASE | 2 |
| outbreaks | TAXON | 2 |
| osteonecrosis | DISEASE | 2 |
| organ damage | DISEASE | 2 |
| opportunistic infections | DISEASE | 2 |
| norepinephrine | CHEMICAL | 2 |
| nitrogen | CHEMICAL | 2 |
| nicotinamide adenine | ORG | 2 |
| neutrophilia | ORG | 2 |
| neutrophil infiltration | DISEASE | 2 |
| neurodegeneration | DISEASE | 2 |
| mycobacterium | TAXON | 2 |
| pathogens infections | DISEASE | 2 |
| peroxynitrite | CHEMICAL | 2 |
| mouthwash | CHEMICAL | 2 |
| phenobarbital | CHEMICAL | 2 |
| psychiatric | DISEASE | 2 |
| protracted illness | DISEASE | 2 |
| protozoan parasites | TAXON | 2 |
| proteinuria | DISEASE | 2 |
| prostatic hyperplasia bph | DISEASE | 2 |
| prostatic hyperplasia | DISEASE | 2 |
| prostaglandins | CHEMICAL | 2 |
| prostaglandin e2 | CHEMICAL | 2 |
| prostaglandin | CHEMICAL | 2 |
| prostacyclin | GPE | 2 |
| porcine | TAXON | 2 |
| polyunsaturated fatty acids | CHEMICAL | 2 |
| polio | DISEASE | 2 |
| platelet fibrin thrombi | DISEASE | 2 |
| pig | TAXON | 2 |
| mycobacterial | TAXON | 2 |
| montelukast sodium | CHEMICAL | 2 |
| interstitial lung disease | DISEASE | 2 |
| lntb10 | CHEMICAL | 2 |
| lisofylline | CHEMICAL | 2 |
| leukopenia | GPE | 2 |
| leukemia | DISEASE | 2 |
| leptin leptin | PERSON | 2 |
| lanthanides | CHEMICAL | 2 |
| kilometres | TAXON | 2 |
| kidneys | GPE | 2 |
| kappa b nf | PERSON | 2 |
| juvenile osteopetrosis | DISEASE | 2 |
| isopentenyladenosine | CHEMICAL | 2 |
| ischaemia | DISEASE | 2 |
| intracranial infection | DISEASE | 2 |
| intraalveolar lipid laden macrophages | ORG | 2 |
| intestinal inflammation | DISEASE | 2 |
| interstitial pneumonia | DISEASE | 2 |
| liver damage | DISEASE | 2 |
| loss | DISEASE | 2 |
| midazolam | CHEMICAL | 2 |
| lung edema | DISEASE | 2 |
| microbial infection | DISEASE | 2 |
| microbes virus | TAXON | 2 |
| microbe | TAXON | 2 |
| methionine sulfoxide peptide | CHEMICAL | 2 |
| metastasis | DISEASE | 2 |
| metabolic complications | DISEASE | 2 |
| marine sponge | TAXON | 2 |
| marine | TAXON | 2 |
| maltodextrin | CHEMICAL | 2 |
| malignancy | DISEASE | 2 |
| malarial | TAXON | 2 |
| lymphocytopenia | DISEASE | 2 |
| lupus erythematosus | DISEASE | 2 |
| lupus | DISEASE | 2 |
| lung inflammatory injury | DISEASE | 2 |
| pteridines | CHEMICAL | 2 |
| pulmonary disease | DISEASE | 2 |
| pulmonary diseases | DISEASE | 2 |
| viral fragment | TAXON | 2 |
| viral conjunctivitis | DISEASE | 2 |
| viral cellular | TAXON | 2 |
| viral capsid | TAXON | 2 |
| verapamil | CHEMICAL | 2 |
| vasoplegia | DISEASE | 2 |
| vascular insult | DISEASE | 2 |
| vascular inflammation | DISEASE | 2 |
| vascular diseases | DISEASE | 2 |
| valproic acid co a | CHEMICAL | 2 |
| valproate | CHEMICAL | 2 |
| v5ndlk9c | DISEASE | 2 |
| uremia | DISEASE | 2 |
| type 2 diabetes fh dm2 | DISEASE | 2 |
| tumour necrosis | DISEASE | 2 |
| tryptophan | GPE | 2 |
| viral destruction | DISEASE | 2 |
| viral genomes | TAXON | 2 |
| pulmonary embolism | DISEASE | 2 |
| viral hepatitis | DISEASE | 2 |
| zanamivir | CHEMICAL | 2 |
| zn 2 | PERSON | 2 |
| z70oevy2 | TAXON | 2 |
| warfarin | CHEMICAL | 2 |
| volume induced lung injury | DISEASE | 2 |
| virus type 1 hiv 1 | TAXON | 2 |
| virus poliovirus human | TAXON | 2 |
| virus particles | TAXON | 2 |
| virus tmv | TAXON | 2 |
| virions | TAXON | 2 |
| viral sepsis | DISEASE | 2 |
| viral respiratory disease | DISEASE | 2 |
| viral protein | TAXON | 2 |
| viral multisystem disease | DISEASE | 2 |
| viral loss | DISEASE | 2 |
| torsade de pointes arrhythmias | DISEASE | 2 |
| tocotrienol | CHEMICAL | 2 |
| threonine | CHEMICAL | 2 |
| theophylline | CHEMICAL | 2 |
| respiratory tract infections | DISEASE | 2 |
| respiratory syndrome coronavirus mers | DISEASE | 2 |
| respiratory syndrome corona virus 2 sars | DISEASE | 2 |
| respiratory insufficiency | DISEASE | 2 |
| respiratory and cardiac problems | DISEASE | 2 |
| reproductive dysfunction | DISEASE | 2 |
| renal injury | DISEASE | 2 |
| renal failure | DISEASE | 2 |
| renal damage | DISEASE | 2 |
| reduction in pulmonary compliance | DISEASE | 2 |
| reduction in lung compliance | DISEASE | 2 |
| pyruvate | CHEMICAL | 2 |
| pulmonary thrombosis | DISEASE | 2 |
| pulmonary microvascular thrombosis | DISEASE | 2 |
| pulmonary insult | DISEASE | 2 |
| respiratory virus infection | DISEASE | 2 |
| rodentium | TAXON | 2 |
| sarcoidosis | DISEASE | 2 |
| sulphuric acid hydrogen sulfide | CHEMICAL | 2 |
| the u s | GPE | 2 |
| the severe acute respiratory syndrome coronavirus | ORG | 2 |
| the middle east respiratory syndrome third aat | LOC | 2 |
| the abo blood group | ORG | 2 |
| tetrahydrocannabinol thc | CHEMICAL | 2 |
| systemic injury | DISEASE | 2 |
| sterol | CHEMICAL | 2 |
| saturated fatty acids | CHEMICAL | 2 |
| stabilizers | CHEMICAL | 2 |
| squamous cell carcinoma oscc | DISEASE | 2 |
| small airways and alveolar trauma | DISEASE | 2 |
| septicemia | DISEASE | 2 |
| selenocysteine | CHEMICAL | 2 |
| scleroderma | DISEASE | 2 |
| interstitial lung diseases | DISEASE | 2 |
| the nlrp3 inflammasome pathway il1β | ORG | 2 |
| insulin deficiency | DISEASE | 2 |
| chimpanzees | TAXON | 2 |
| chemiluminescence | CHEMICAL | 2 |
| cerebral infection | DISEASE | 2 |
| central obesity | DISEASE | 2 |
| cell injury | DISEASE | 2 |
| cell damage | DISEASE | 2 |
| cardiovascular metabolic diseases | DISEASE | 2 |
| cardiovascular diseases | DISEASE | 2 |
| cardiogenic pulmonary edema | DISEASE | 2 |
| carbon sugars | CHEMICAL | 2 |
| carbohydrate | CHEMICAL | 2 |
| canine | TAXON | 2 |
| cancers | DISEASE | 2 |
| camostat | CHEMICAL | 2 |
| cchloroquine | ORG | 2 |
| c2edfd27768a4cf69263a8abe65a8e2c22683e58 | ORG | 2 |
| chilblains | CHEMICAL | 2 |
| chlorhexidine | CHEMICAL | 2 |
| dendritic cell infection | DISEASE | 2 |
| chlorotaurine | DISEASE | 2 |
| defensin | CHEMICAL | 2 |
| cytolysis | DISEASE | 2 |
| creatine | CHEMICAL | 2 |
| cream | CHEMICAL | 2 |
| corticosteroids | CHEMICAL | 2 |
| coronavirus strain 2019 ncov | DISEASE | 2 |
| coronavirus infected | DISEASE | 2 |
| coronavirus diseases covid | DISEASE | 2 |
| coronavirus mers | DISEASE | 2 |
| coronary artery disease | DISEASE | 2 |
| congestive heart failure | DISEASE | 2 |
| colchicine | CHEMICAL | 2 |
| coagulopathic | DISEASE | 2 |
| clarithromycin | CHEMICAL | 2 |
| chronic multi organ inflammatory disease | DISEASE | 2 |
| burn | DISEASE | 2 |
| bronchitis | DISEASE | 2 |
| bevacizumab | CHEMICAL | 2 |
| bcgindex | CHEMICAL | 2 |
| adenoviruses | TAXON | 2 |
| adenosine triphosphate | CHEMICAL | 2 |
| adenosin mono phosphate | CHEMICAL | 2 |
| acute respiratory syndrome coronavirus spike | DISEASE | 2 |
| acute respiratory infections | DISEASE | 2 |
| acute lung lesion | DISEASE | 2 |
| acute lung inflammation | DISEASE | 2 |
| acute liver injury | DISEASE | 2 |
| acid | CHEMICAL | 2 |
| acetylgalactosamine | CHEMICAL | 2 |
| acetaminophen | CHEMICAL | 2 |
| abnormal renal function | DISEASE | 2 |
| injury | DISEASE | 2 |
| zn doped | PERSON | 2 |
| abnormal coagulation | DISEASE | 2 |
| alanine | CHEMICAL | 2 |
| aldosterone | CHEMICAL | 2 |
| allicin | CHEMICAL | 2 |
| arrhythmias | DISEASE | 2 |
| bacterial superinfection | DISEASE | 2 |
| bacterial infections | DISEASE | 2 |
| avian influenza | PERSON | 2 |
| autoimmune diseases | DISEASE | 2 |
| atopic dermatitis | DISEASE | 2 |
| atelectasis | DISEASE | 2 |
| antiphospholipid | DISEASE | 2 |
| alpha 1 antitrypsin deficiency | CHEMICAL | 2 |
| anosmia | DISEASE | 2 |
| animal cells | TAXON | 2 |
| angiotensin peptides | CHEMICAL | 2 |
| angiotensin 1 7 a | CHEMICAL | 2 |
| anemia | DISEASE | 2 |
| aminoglycosides | CHEMICAL | 2 |
| dementia | DISEASE | 2 |
| angiopathy | DISEASE | 2 |
| dengue fever | DISEASE | 2 |
| human respiratory syncytial virus | TAXON | 2 |
| human monocytes | TAXON | 2 |
| human hepatocyte | TAXON | 2 |
| human erythrocytes | TAXON | 2 |
| human coronaviruses | TAXON | 2 |
| human contact | TAXON | 2 |
| human alveolar macrophages | TAXON | 2 |
| herpes | DISEASE | 2 |
| hepatitis | DISEASE | 2 |
| hepatic coagulation | DISEASE | 2 |
| heparan sulfate | CHEMICAL | 2 |
| hemorrhagic consumptive coagulopathy annexin v | DISEASE | 2 |
| hemorrhage | DISEASE | 2 |
| hemophilia | GPE | 2 |
| heart liver and kidney | DISEASE | 2 |
| heart kidney gastrointestinal tract | DISEASE | 2 |
| human polymorphonuclear leukocytes | TAXON | 2 |
| human rhinovirus | TAXON | 2 |
| haemolysis | DISEASE | 2 |
| hydrochloric acid | CHEMICAL | 2 |
| influenza finally | ORG | 2 |
| influenza ards | DISEASE | 2 |
| influenza outbreaks | GPE | 2 |
| depressed | DISEASE | 2 |
| influenza a virus infection | DISEASE | 2 |
| inflammatory lung injury | DISEASE | 2 |
| inflammatory lung disease | DISEASE | 2 |
| inflammatory bowel disease | DISEASE | 2 |
| inflammation obesity | DISEASE | 2 |
| infectious respiratory disease | DISEASE | 2 |
| infection disease | DISEASE | 2 |
| idiopathic pulmonary fibrosis | DISEASE | 2 |
| hypoxaemia | DISEASE | 2 |
| hydrogen peroxide chloride | CHEMICAL | 2 |
| hydrogen peroxide h 2 o | CHEMICAL | 2 |
| heart disease | DISEASE | 2 |
| hydroxyl | CHEMICAL | 2 |
| gsk4qel5 | DISEASE | 2 |
| edema | DISEASE | 2 |
| estrogens | CHEMICAL | 2 |
| ester | CHEMICAL | 2 |
| epigallocatechin gallate | CHEMICAL | 2 |
| depressive | DISEASE | 2 |
| epigallocatechin 3 gallate | CHEMICAL | 2 |
| endotoxin | CHEMICAL | 2 |
| endothelial cell dysfunction | DISEASE | 2 |
| dutasteride | CHEMICAL | 2 |
| extensive lung damage | DISEASE | 2 |
| dry cough fatigue | DISEASE | 2 |
| disorder | DISEASE | 2 |
| dipyridamole dipyridamole | PERSON | 2 |
| grape seed | CHEMICAL | 2 |
| diabetes cardiovascular disease | DISEASE | 2 |
| diabetic medicines | DISEASE | 2 |
| dipyridamole dip | CHEMICAL | 2 |
| ethyl pyruvate | CHEMICAL | 2 |
| endothelial cell damage | DISEASE | 2 |
| faeces | TAXON | 2 |
| flavin | CHEMICAL | 2 |
| failure of the blood | DISEASE | 2 |
| granulysin | CHEMICAL | 2 |
| glucan | CHEMICAL | 2 |
| gaps | CHEMICAL | 2 |
| granuloma | DISEASE | 2 |
| fructose | CHEMICAL | 2 |
| fulminant myocarditis | DISEASE | 2 |
| fibronectin | ORG | 2 |
| fibrin | TAXON | 2 |
| fever nasal congestion | DISEASE | 2 |
| fever cough | DISEASE | 2 |
| fenoterol | CHEMICAL | 2 |
| glucosamine | CHEMICAL | 2 |
| mycobacterium terrae | CHEMICAL | 1 |
| mycobacterium tuberculosis infection | CHEMICAL | 1 |
| mycobacterium spp exposure | ORG | 1 |
| myeloid | ORG | 1 |
| mycobacterium spp | TAXON | 1 |
| monosodium urate | PERSON | 1 |
| myanmar | GPE | 1 |
| murray | GPE | 1 |
| murine norovirus | TAXON | 1 |
| murch simon h | PERSON | 1 |
| mt etna italy gravitational | PERSON | 1 |
| multiple sclerosis | PERSON | 1 |
| multiple linear | ORG | 1 |
| mufson maurice | PERSON | 1 |
| mt etna sicily | PERSON | 1 |
| mt etna lung | PERSON | 1 |
| ms alejandra maldonado | GPE | 1 |
| most new york coronavirus cases came from europe | GPE | 1 |
| mossel | ORG | 1 |
| mosquito | TAXON | 1 |
| müller | PERSON | 1 |
| monteil | ORG | 1 |
| moore | PERSON | 1 |
| myopathy | DISEASE | 1 |
| n succinimidyl 3 trimethylstannyl benzoate | CHEMICAL | 1 |
| n apn | ORG | 1 |
| n acetyl cysteine | CHEMICAL | 1 |
| nfat | ORG | 1 |
| nf kappab | ORG | 1 |
| netosis | ORG | 1 |
| modification of neutrophil | ORG | 1 |
| nct04320615 a | DISEASE | 1 |
| ncbi epidemiological | ORG | 1 |
| nadp nadph | CHEMICAL | 1 |
| nad nadp | CHEMICAL | 1 |
| nad nadh | ORG | 1 |
| nad nad | ORG | 1 |
| n1098 | ORG | 1 |
| n title phosphatidylglycerol | CHEMICAL | 1 |
| n terminal domain | CHEMICAL | 1 |
| n methyl n 0 nitro n nitrosoguanidine | CHEMICAL | 1 |
| n methyl n 0 | ORG | 1 |
| n hydroxypyridinethiones a 214 | CHEMICAL | 1 |
| n chlorotaurine chloramines | ORG | 1 |
| n chloro p toluene sulfonamide | CHEMICAL | 1 |
| n chloramines | CHEMICAL | 1 |
| n chloramine h 2 o 2 p iodophenol system iodination of | CHEMICAL | 1 |
| n acetylglucosamine | CHEMICAL | 1 |
| n acetyl l cysteine nac | CHEMICAL | 1 |
| n acetyl | ORG | 1 |
| n terminal domain | ORG | 1 |
| n acetylglucosamine | CHEMICAL | 1 |
| molecular insight | ORG | 1 |
| membrane | ORG | 1 |
| modificaiton | PERSON | 1 |
| mcsorley | LOC | 1 |
| merck | ORG | 1 |
| menkes disease cu deficiency | DISEASE | 1 |
| men aging | ORG | 1 |
| melanoma | DISEASE | 1 |
| mehta meenu | PERSON | 1 |
| mehraban | CHEMICAL | 1 |
| meenakshisundaram ramachandran | PERSON | 1 |
| medscape | ORG | 1 |
| mediterranean basin rare earth | CHEMICAL | 1 |
| medical and preventive facilities | ORG | 1 |
| med drug | PERSON | 1 |
| matthay | ORG | 1 |
| metabolic syndrome | DISEASE | 1 |
| mathieu | ORG | 1 |
| mathematical | ORG | 1 |
| massad | GPE | 1 |
| mass | GPE | 1 |
| maslach | ORG | 1 |
| mascone | CHEMICAL | 1 |
| mas renin angiotensin aldosterone system inhibitors | PERSON | 1 |
| mas 13 | PERSON | 1 |
| martin | PERSON | 1 |
| nk dc | GPE | 1 |
| marr | PERSON | 1 |
| met leu phe | PERSON | 1 |
| metabolic syndrome | DISEASE | 1 |
| model | PERSON | 1 |
| microvascular thrombotic complications | DISEASE | 1 |
| mitzie | DISEASE | 1 |
| mitogen | PERSON | 1 |
| mitf | PERSON | 1 |
| minority ethnic bame | ORG | 1 |
| minetti giampaolo | PERSON | 1 |
| miller | PERSON | 1 |
| mild | ORG | 1 |
| mike stobbe | PERSON | 1 |
| middle east respiratory syndrome mers coronavirus contamination | LOC | 1 |
| middle east respiratory syndrome coronavirus maps | LOC | 1 |
| middle east respiratory syndrome coronavirus | LOC | 1 |
| microparticles | GPE | 1 |
| metalloproteinase domain 17 | PERSON | 1 |
| microbes infect influence | PERSON | 1 |
| microbes infect | PERSON | 1 |
| microbes | TAXON | 1 |
| mice virus | TAXON | 1 |
| mice importance | LOC | 1 |
| mice fatty acid | TAXON | 1 |
| mice balb | PERSON | 1 |
| metin donma orkide | CHEMICAL | 1 |
| methionine sulfoxide | CHEMICAL | 1 |
| methionine | PERSON | 1 |
| metamodels | CHEMICAL | 1 |
| nga | CHEMICAL | 1 |
| novaes rocha vinicius | PERSON | 1 |
| nk cells dc | GPE | 1 |
| nmr | ORG | 1 |
| opmds osmf | DISEASE | 1 |
| opmds coronavirus disease | DISEASE | 1 |
| opg | ORG | 1 |
| opd | ORG | 1 |
| oes | ORG | 1 |
| o2 | CHEMICAL | 1 |
| nutraceuticals | ORG | 1 |
| nurses working | PERSON | 1 |
| nuevo | GPE | 1 |
| nucleotide | ORG | 1 |
| nozik grayck | PERSON | 1 |
| notwithstanding sars cov | ORG | 1 |
| norway | GPE | 1 |
| norwalk virus | TAXON | 1 |
| norwalk | ORG | 1 |
| northern italy | LOC | 1 |
| northeast sicily | PERSON | 1 |
| north korea | GPE | 1 |
| normal pregnancy | LOC | 1 |
| noradrenergic | LOC | 1 |
| none supplementary | PERSON | 1 |
| nonalcoholic fatty liver disease | DISEASE | 1 |
| nonalcoholic fatty liver disease | DISEASE | 1 |
| noble euan | PERSON | 1 |
| nitric oxide no | CHEMICAL | 1 |
| orf8 c251t s84l | PERSON | 1 |
| occupational | ORG | 1 |
| ocular toxicity | DISEASE | 1 |
| overall sars cov 2 | ORG | 1 |
| maria sklodowska | PERSON | 1 |
| pah lesions | DISEASE | 1 |
| pah | CHEMICAL | 1 |
| p38 jnk atf | ORG | 1 |
| p2x7 | GPE | 1 |
| ozdemir burak | PERSON | 1 |
| oxidized cu | ORG | 1 |
| oxidative stress and inflammation in cardiovascular disease current status of cell based therapies for respiratory virus infections applicability | ORG | 1 |
| oxidative stress | ORG | 1 |
| oxidation | ORG | 1 |
| oxford | PERSON | 1 |
| osteoarthr cartil | ORG | 1 |
| off | CHEMICAL | 1 |
| osaka | GPE | 1 |
| orthocoronavirinae | PERSON | 1 |
| organizational causes and interventions | ORG | 1 |
| oral | ORG | 1 |
| opposing immunoregulatory functions | ORG | 1 |
| opportunistic | DISEASE | 1 |
| olsen | PERSON | 1 |
| olivier martin | PERSON | 1 |
| olfactory and gustatory dysfunctions | DISEASE | 1 |
| oldie | PERSON | 1 |
| older adults editorial advances | ORG | 1 |
| nitric oxide synthase activation | ORG | 1 |
| nioi | PERSON | 1 |
| nikolina basic jukic | PERSON | 1 |
| nacetyl cysteine | CHEMICAL | 1 |
| national | ORG | 1 |
| nat coronavirus | PERSON | 1 |
| naringin | CHEMICAL | 1 |
| narayan ravi | PERSON | 1 |
| napolitano maddalena | ORG | 1 |
| napoli | ORG | 1 |
| nanomedicine for topical delivery in skin disorders current and translational | ORG | 1 |
| nanoethics | LOC | 1 |
| nanoflu tm | PERSON | 1 |
| nan fang | PERSON | 1 |
| naming the coronavirus disease covid | DISEASE | 1 |
| nacetyl | ORG | 1 |
| national institutes of health | ORG | 1 |
| naocl chloramines | CHEMICAL | 1 |
| na þ | PERSON | 1 |
| nyha ii iv | ORG | 1 |
| nyc | ORG | 1 |
| nsaids | CHEMICAL | 1 |
| ns8 | PERSON | 1 |
| ns7b | CHEMICAL | 1 |
| nps | CHEMICAL | 1 |
| nod | ORG | 1 |
| no2 | ORG | 1 |
| no transforming | ORG | 1 |
| national health commission of the people s republic of china diagnosis | ORG | 1 |
| national institutes of health national eye institute | ORG | 1 |
| nikolina | CHEMICAL | 1 |
| new york city ny | ORG | 1 |
| nikhil diagnotek xact | PERSON | 1 |
| nicotine | CHEMICAL | 1 |
| nicotinamide adenine dinucleotide nad nad | CHEMICAL | 1 |
| nicotinamide adenine dinucleotide nad | CHEMICAL | 1 |
| nicotinamide adenine dinucleotide | ORG | 1 |
| nicotiana | GPE | 1 |
| nicholas p henshaw | PERSON | 1 |
| niall | CHEMICAL | 1 |
| ng | CHEMICAL | 1 |
| new zealand | GPE | 1 |
| new york heart association | ORG | 1 |
| new york 6 | GPE | 1 |
| national natural science | ORG | 1 |
| new york | GPE | 1 |
| new orleans fox | GPE | 1 |
| neutrophil elastase contributes | PERSON | 1 |
| neuronal m | ORG | 1 |
| neurological manifestations of hospitalized patients | ORG | 1 |
| neural network metamodels | ORG | 1 |
| netherlands | GPE | 1 |
| nepal | GPE | 1 |
| negative | ORG | 1 |
| nature | ORG | 1 |
| native | GPE | 1 |
| mario boccardo | PERSON | 1 |
| josé | DISEASE | 1 |
| marcus cremonese medical illustration | ORG | 1 |
| mani mishra pushpendra uversky | PERSON | 1 |
| junin and herpes simplex viruses | TAXON | 1 |
| jun sun | PERSON | 1 |
| jun n terminal kinase | ORG | 1 |
| jr photodynamic | GPE | 1 |
| josé caetano silva | PERSON | 1 |
| pbpk | CHEMICAL | 1 |
| joshua | PERSON | 1 |
| joseph leavitt alida | PERSON | 1 |
| john p | PERSON | 1 |
| jiangsu province | GPE | 1 |
| jiajia | DISEASE | 1 |
| jessica buck | PERSON | 1 |
| jerome treton | PERSON | 1 |
| japan usa | ORG | 1 |
| janssen rob walk jona | PERSON | 1 |
| janaína lima de oliveira writing | ORG | 1 |
| jan juszczak kajetan | ORG | 1 |
| james dumbauld | PERSON | 1 |
| james | PERSON | 1 |
| jacota | CHEMICAL | 1 |
| jun xpo1 gene | PERSON | 1 |
| its dependence on free area effect of hyperpnea | GPE | 1 |
| italy spain | GPE | 1 |
| italy relationship | GPE | 1 |
| italy casual | ORG | 1 |
| k k k | CHEMICAL | 1 |
| k kumari chiman faiq muneeb a kulandhasamy maheswari kant kamla | ORG | 1 |
| k n and c k | CHEMICAL | 1 |
| kim | PERSON | 1 |
| l burm | PERSON | 1 |
| l anthraquinone 2 6 disulfonic acid | CHEMICAL | 1 |
| kv3 | CHEMICAL | 1 |
| kupffer | PERSON | 1 |
| kumar pradeep | ORG | 1 |
| kumar khosla | PERSON | 1 |
| kokn | CHEMICAL | 1 |
| kocaman sinan | PERSON | 1 |
| kobe | GPE | 1 |
| kinlen 28 | PERSON | 1 |
| kin hang kokn | PERSON | 1 |
| kidney and testis | DISEASE | 1 |
| k channel | ORG | 1 |
| khitan zeid | PERSON | 1 |
| ketonuria | GPE | 1 |
| kerrigan | PERSON | 1 |
| kentucky | GPE | 1 |
| kennedy james | PERSON | 1 |
| kavanagh oisín marie healy | PERSON | 1 |
| katoh | PERSON | 1 |
| karlman wasserman | PERSON | 1 |
| karaahmet fatih | PERSON | 1 |
| kara kockelman karim karouta | PERSON | 1 |
| kakodkar kaka | PERSON | 1 |
| italy calabria | GPE | 1 |
| italian superior institute of health | ORG | 1 |
| italia | ORG | 1 |
| indo pakistanis | ORG | 1 |
| influenza b 506 | DISEASE | 1 |
| infliximab | CHEMICAL | 1 |
| inflammatory bowel disease | DISEASE | 1 |
| inflammation by regulating leukocyte | ORG | 1 |
| inflammation research special | ORG | 1 |
| infectious diseases | DISEASE | 1 |
| infectious disease | DISEASE | 1 |
| infection coronavirus | DISEASE | 1 |
| infection clinical characteristics | ORG | 1 |
| induction of interferon | ORG | 1 |
| indoor air quality | ORG | 1 |
| indo | CHEMICAL | 1 |
| influenza other respi 425 | ORG | 1 |
| individual genetic susceptibility receptivity role | ORG | 1 |
| imran | CHEMICAL | 1 |
| importantly 10 | LOC | 1 |
| implications of the angiotensin converting enzyme gene | ORG | 1 |
| immunothrombosis | CHEMICAL | 1 |
| immunopharmacological | ORG | 1 |
| immunoelectron | ORG | 1 |
| immunity | PERSON | 1 |
| imidazole derivative | ORG | 1 |
| illinois | GPE | 1 |
| igm | ORG | 1 |
| influenza b 506 identification | ORG | 1 |
| influenza virus infections | DISEASE | 1 |
| isabela tanuri bessa | PERSON | 1 |
| interstitial pneumonia | DISEASE | 1 |
| irwin | PERSON | 1 |
| iron | CHEMICAL | 1 |
| iran | GPE | 1 |
| ionizing | CHEMICAL | 1 |
| invitrogen co ltd | ORG | 1 |
| investigative | ORG | 1 |
| invades | CHEMICAL | 1 |
| intubation and ventilation | ORG | 1 |
| introduction individuals | ORG | 1 |
| intravenous nac | ORG | 1 |
| intestinal inflammation | DISEASE | 1 |
| interstitial lung disease | DISEASE | 1 |
| inhalation of hydrocarbon | ORG | 1 |
| international diabetes federation | ORG | 1 |
| interim | ORG | 1 |
| interaction of water droplets | ORG | 1 |
| interaction of bacillus | ORG | 1 |
| intensive care medicine a | ORG | 1 |
| intensive | ORG | 1 |
| intechopen | ORG | 1 |
| instrumental variable method analysis | ORG | 1 |
| institute of medicine us panel | ORG | 1 |
| insight | ORG | 1 |
| innate immunity activation | ORG | 1 |
| l fucose | CHEMICAL | 1 |
| lbt | ORG | 1 |
| lbt infections | DISEASE | 1 |
| lymphocyte | ORG | 1 |
| mdri | ORG | 1 |
| md 2 | ORG | 1 |
| mct 4 | ORG | 1 |
| mcsf | ORG | 1 |
| mas | ORG | 1 |
| m2e | ORG | 1 |
| lyu jinglu miao | PERSON | 1 |
| lysosomal | GPE | 1 |
| lymphoid | ORG | 1 |
| lymphocytic | LOC | 1 |
| lymphocyte ratio | ORG | 1 |
| luzon | GPE | 1 |
| mers cov 37 | ORG | 1 |
| luoma | GPE | 1 |
| luo xiangying | PERSON | 1 |
| lung injury | DISEASE | 1 |
| lung cancer | DISEASE | 1 |
| lung surfactant on mucus | ORG | 1 |
| lung | PERSON | 1 |
| lumbardy decreto iorestoacasa | ORG | 1 |
| luar chemistry | ORG | 1 |
| lower | ORG | 1 |
| lovastatin immune modulatory effects | LOC | 1 |
| lovastatin | CHEMICAL | 1 |
| mdsc | LOC | 1 |
| mers cov ntd | ORG | 1 |
| loredana calabrò | PERSON | 1 |
| madapusi | CHEMICAL | 1 |
| manenti antonio palmieri beniamino | PERSON | 1 |
| mandi himachal | PERSON | 1 |
| management of inpatient pregnant women infected | ORG | 1 |
| man yu | PERSON | 1 |
| mammalian | TAXON | 1 |
| maldonado valente loza | PERSON | 1 |
| malaria an epidemiological paradox | ORG | 1 |
| mahnaz zarshenas mohammad m title bioactive compounds | PERSON | 1 |
| mahmoud | PERSON | 1 |
| magro | ORG | 1 |
| madapusi balaji | PERSON | 1 |
| macrophages deletion polymorphism | TAXON | 1 |
| mers cov sars cov 2 viral load in upper respiratory specimens of infected patients differential | ORG | 1 |
| mackman | PERSON | 1 |
| mpo | ORG | 1 |
| mods | CHEMICAL | 1 |
| mmr je | CHEMICAL | 1 |
| mmp 9 hypoxia | ORG | 1 |
| mmp | ORG | 1 |
| mip 2 13 | ORG | 1 |
| mhc | ORG | 1 |
| mg132 | CHEMICAL | 1 |
| met 1690 | CHEMICAL | 1 |
| mers cov infection | DISEASE | 1 |
| loss | PERSON | 1 |
| lopinavir ritonavir | CHEMICAL | 1 |
| ldh | ORG | 1 |
| laos | GPE | 1 |
| leptin s | PERSON | 1 |
| lepique | DISEASE | 1 |
| lepr mrna | PERSON | 1 |
| leica dmi4000b | PERSON | 1 |
| leica | GPE | 1 |
| lee hanjun | PERSON | 1 |
| lee | PERSON | 1 |
| law | PERSON | 1 |
| lava | ORG | 1 |
| latest | ORG | 1 |
| largely | PERSON | 1 |
| lanthanides | CHEMICAL | 1 |
| leukotriene e4 | PERSON | 1 |
| langmuir | ORG | 1 |
| lalani | PERSON | 1 |
| laboratory | GPE | 1 |
| la | GPE | 1 |
| lte4 | CHEMICAL | 1 |
| ltd4 | CHEMICAL | 1 |
| ltbis furthermore m | ORG | 1 |
| ltbis furthermore | CHEMICAL | 1 |
| lsm710 | PERSON | 1 |
| lmwh | ORG | 1 |
| literature internal | ORG | 1 |
| leukocyte | PERSON | 1 |
| leukotrienes | CHEMICAL | 1 |
| lopez luis f coutinho francisco | PERSON | 1 |
| lipsker dan | PERSON | 1 |
| longevity | DISEASE | 1 |
| london | GPE | 1 |
| lombardia | PERSON | 1 |
| lodigiani | PERSON | 1 |
| lodi cremona | PERSON | 1 |
| lmethionine | CHEMICAL | 1 |
| liver disease | DISEASE | 1 |
| liver and kidney injuries | DISEASE | 1 |
| liver dysfunction | DISEASE | 1 |
| liu bin | PERSON | 1 |
| lipsker dan title a | CHEMICAL | 1 |
| lippi et al | PERSON | 1 |
| levetiracetam | CHEMICAL | 1 |
| lipoproteins | CHEMICAL | 1 |
| lipid profile zinc | ORG | 1 |
| linked | PERSON | 1 |
| linactants physical | ORG | 1 |
| lin | PERSON | 1 |
| lim rachel k | PERSON | 1 |
| likert | ORG | 1 |
| lifestyle | ORG | 1 |
| liang xiaolong | PERSON | 1 |
| lewis | PERSON | 1 |
| levi | PERSON | 1 |
| pai | ORG | 1 |
| reduced covid | DISEASE | 1 |
| pcr prevalence of murine opportunistic microbes | ORG | 1 |
| pd | DISEASE | 1 |
| shoieb sherif | DISEASE | 1 |
| shi | PERSON | 1 |
| sheahan | PERSON | 1 |
| sharon worcester | PERSON | 1 |
| sharon begley | PERSON | 1 |
| shapiro joseph | PERSON | 1 |
| shankargouda | CHEMICAL | 1 |
| shankar karunasagar | PERSON | 1 |
| shanghai inhibition | ORG | 1 |
| shailesh | CHEMICAL | 1 |
| shahrukh k | CHEMICAL | 1 |
| sex hormones | PERSON | 1 |
| severe alcoholic hepatitis intricate roles of mammalian sirtuins in defense against | ORG | 1 |
| severe acute respiratory syndrome coronavirus | ORG | 1 |
| serum gc | LOC | 1 |
| serum albumin | PERSON | 1 |
| serpin | ORG | 1 |
| serological cross | ORG | 1 |
| ser sec | PERSON | 1 |
| septic shock | DISEASE | 1 |
| senthilkumaran | CHEMICAL | 1 |
| sensitive | ORG | 1 |
| seattle | GPE | 1 |
| science | ORG | 1 |
| sato | CHEMICAL | 1 |
| shoolini university solan | ORG | 1 |
| sialic | ORG | 1 |
| sialic acid | CHEMICAL | 1 |
| sirtuins link inflammation and metabolism induction | ORG | 1 |
| soil 222rn | PERSON | 1 |
| sodium valproate | CHEMICAL | 1 |
| sodium hypochlorite | CHEMICAL | 1 |
| sodium chloride | CHEMICAL | 1 |
| social | ORG | 1 |
| smallpox | PERSON | 1 |
| smad | LOC | 1 |
| skp2 | ORG | 1 |
| sklodowska curie | DISEASE | 1 |
| sjogren s syndrome | DISEASE | 1 |
| sirukumab | PERSON | 1 |
| sirt1 tnf | PERSON | 1 |
| sicily air | ORG | 1 |
| singulair | PERSON | 1 |
| sin wi | PERSON | 1 |
| sin | DISEASE | 1 |
| simplifying | GPE | 1 |
| simplex virus 1 hsv 1 | TAXON | 1 |
| similarly ang ii | PERSON | 1 |
| silico | GPE | 1 |
| siglecs siglec 3 | PERSON | 1 |
| sierra leone west africa mental | ORG | 1 |
| sierra leone | CHEMICAL | 1 |
| sicily clinical | ORG | 1 |
| sargan | ORG | 1 |
| sarda | TAXON | 1 |
| saranya madapusi | CHEMICAL | 1 |
| sars cov mers | DISEASE | 1 |
| sars coronavirus infection | DISEASE | 1 |
| sars coronavirus a pneumonia | DISEASE | 1 |
| sars coronavirus a | DISEASE | 1 |
| sars corona virus infection | DISEASE | 1 |
| sars cov 2 infection | DISEASE | 1 |
| sars cov pneumonia | DISEASE | 1 |
| sars cov infections | DISEASE | 1 |
| sars cov structure function and antigenicity of | ORG | 1 |
| sars cov sars cov 2 | ORG | 1 |
| sars cov mechanism of action of | ORG | 1 |
| sars cov mers cov | ORG | 1 |
| sars cov human | ORG | 1 |
| sars pneumonia | DISEASE | 1 |
| sars cov cell | ORG | 1 |
| sars cov based | ORG | 1 |
| sars cov 35 | ORG | 1 |
| sars cov 26 | ORG | 1 |
| sars cov 25 | ORG | 1 |
| sars cov 2 its | ORG | 1 |
| sars cov 2 infection characteristics of ocular findings of patients with coronavirus | ORG | 1 |
| sars cov 2 date 2020 04 24 | ORG | 1 |
| sars cov 2 arxvi 2020 comprehensive | ORG | 1 |
| sars cov 2 and sars cov | ORG | 1 |
| sars cov 2 world health organization clinical | ORG | 1 |
| sars infection | DISEASE | 1 |
| sarscov | TAXON | 1 |
| saranya | CHEMICAL | 1 |
| sysadoa | PERSON | 1 |
| sara mascone | PERSON | 1 |
| sapporo ocular | ORG | 1 |
| sanita | CHEMICAL | 1 |
| sangon | GPE | 1 |
| sangith nikhil diagnotek xact | CHEMICAL | 1 |
| sandhaus | CHEMICAL | 1 |
| sanabria juan r | PERSON | 1 |
| saisei mirai | ORG | 1 |
| saikosaponins | CHEMICAL | 1 |
| saharan | CHEMICAL | 1 |
| sahara | LOC | 1 |
| stn | ORG | 1 |
| sds | ORG | 1 |
| string | ORG | 1 |
| stop | PERSON | 1 |
| st segment | ORG | 1 |
| ssris fluoxetine | CHEMICAL | 1 |
| sras cov 2 b direct | ORG | 1 |
| sp b | CHEMICAL | 1 |
| sl | ORG | 1 |
| sirt1 sirt1 | PERSON | 1 |
| sirt1 | PERSON | 1 |
| sgp siglec | ORG | 1 |
| sgp sars cov 2 sgp | ORG | 1 |
| solubility of ibuprofen | ORG | 1 |
| sonia e | CHEMICAL | 1 |
| sos pantelimon 021659 | PERSON | 1 |
| tao huaqiang ge | PERSON | 1 |
| the maillard reaction | ORG | 1 |
| the lancet haematology hypothesis | ORG | 1 |
| the chinese national health commission | ORG | 1 |
| the americas and western europe 3 | LOC | 1 |
| the alpha tocopherol form | ORG | 1 |
| thailand | GPE | 1 |
| th2 | PERSON | 1 |
| tetrahydrocannabinol | CHEMICAL | 1 |
| tetrahydrobiopterin | CHEMICAL | 1 |
| tehran | GPE | 1 |
| technical advisory group for infectious hazards | ORG | 1 |
| tang et al 2020 | PERSON | 1 |
| the north of italy | GPE | 1 |
| tang n | PERSON | 1 |
| tan s | PERSON | 1 |
| tan | PERSON | 1 |
| tamaoki j et al | ORG | 1 |
| takotsubo | ORG | 1 |
| takahashi harutaka | PERSON | 1 |
| taghizadeh | CHEMICAL | 1 |
| ttv | ORG | 1 |
| tpa | CHEMICAL | 1 |
| tnf furthermore | ORG | 1 |
| tmvpositive | ORG | 1 |
| the new york times patient | ORG | 1 |
| the pathogenicity of 2019 | ORG | 1 |
| tmprss 2 41 42 | ORG | 1 |
| time | ORG | 1 |
| identification of fda | ORG | 1 |
| toremifene | PERSON | 1 |
| tong | ORG | 1 |
| tokyo | GPE | 1 |
| tokushima university | ORG | 1 |
| tokushima | CHEMICAL | 1 |
| tocopherols | CHEMICAL | 1 |
| tocopherol succinate | CHEMICAL | 1 |
| tocopherol acetate | CHEMICAL | 1 |
| tocilizumab possible | ORG | 1 |
| tirschenreuth | PERSON | 1 |
| thyroiditis | DISEASE | 1 |
| the washington post | ORG | 1 |
| thus emodin | PERSON | 1 |
| thujaplicin copper | CHEMICAL | 1 |
| thrombus | ORG | 1 |
| thrombotic microangiopathy | DISEASE | 1 |
| thromboembolic disease | DISEASE | 1 |
| thomas w | PERSON | 1 |
| thermophoresis | CHEMICAL | 1 |
| therapeutics | PERSON | 1 |
| their natural inhibitors in inflammatory bowel disease involvement of oxidative stress | ORG | 1 |
| the α tocopherol form of vitamin e reverses age associated susceptibility | ORG | 1 |
| the world health organization | ORG | 1 |
| tmv tmv | PERSON | 1 |
| tmprss 2 | ORG | 1 |
| south america | LOC | 1 |
| steroid | PERSON | 1 |
| structural bases of coronavirus attachment to host aminopeptidase n | ORG | 1 |
| stromal cells | ORG | 1 |
| stroke | DISEASE | 1 |
| streptomyces hygroscopicus streptomyces | TAXON | 1 |
| streptococcus | GPE | 1 |
| strand | GPE | 1 |
| stokes einstein equation | ORG | 1 |
| stokes | ORG | 1 |
| stoke s drag | ORG | 1 |
| stoke | CHEMICAL | 1 |
| steven fabbrocini gabriella | PERSON | 1 |
| stereotactic | PERSON | 1 |
| success | ORG | 1 |
| steckelings | CHEMICAL | 1 |
| statins characterization | ORG | 1 |
| states imaging | ORG | 1 |
| spray | PERSON | 1 |
| spermatogonia leydig | GPE | 1 |
| specific ace2 expression | ORG | 1 |
| spadera lucrezia spadera maria | PERSON | 1 |
| southall and brent revisited cohort | ORG | 1 |
| south and south east asia | LOC | 1 |
| south east asia virology | LOC | 1 |
| south east asia mongolia | LOC | 1 |
| sub saharan africans | PERSON | 1 |
| sulfide | CHEMICAL | 1 |
| tga | DISEASE | 1 |
| susceptibility testing | ORG | 1 |
| tfpi heparin | PERSON | 1 |
| tag | ORG | 1 |
| t lymphocytic cell | DISEASE | 1 |
| t lymphocytes hiv infection | DISEASE | 1 |
| t cell functionality | DISEASE | 1 |
| systemic oxidative stress | ORG | 1 |
| systematic | ORG | 1 |
| synthesis | GPE | 1 |
| sweet | DISEASE | 1 |
| suzuki yuichiro j | PERSON | 1 |
| sushant jae sae young | PERSON | 1 |
| susceptibility | ORG | 1 |
| sultan | PERSON | 1 |
| survanta beraksurf | PERSON | 1 |
| surfaxin | CHEMICAL | 1 |
| surface stability of sars | ORG | 1 |
| surface environmental | PERSON | 1 |
| surface | GPE | 1 |
| supports | DISEASE | 1 |
| superoxide | CHEMICAL | 1 |
| superior institute of health global spread of coronavirus disease 2019 | ORG | 1 |
| supercritical | ORG | 1 |
| suntan | CHEMICAL | 1 |
| sun et al 71 | ORG | 1 |
| sars cov 2 theoretical considerations | ORG | 1 |
| sars cov 2 tmprss 2 | ORG | 1 |
| sars cov 2 suessenbach fk burckhardt bb levels | ORG | 1 |
| polyunsaturated | CHEMICAL | 1 |
| preterm labor | DISEASE | 1 |
| preterm | PERSON | 1 |
| preliminary indoor radon measurements near faults crossing urban areas | ORG | 1 |
| preeclampsia | DISEASE | 1 |
| potential role of gcmaf | ORG | 1 |
| positive | ORG | 1 |
| portugal | GPE | 1 |
| portal | ORG | 1 |
| porphyrin | CHEMICAL | 1 |
| poorer | GPE | 1 |
| ponniah | CHEMICAL | 1 |
| poe francis l | PERSON | 1 |
| preterm labor a missed conclusion antibiotic | ORG | 1 |
| plausible mechanism | ORG | 1 |
| platelet aggregation | DISEASE | 1 |
| plasmodium vivax | DISEASE | 1 |
| plasmodium falciparum malaria | DISEASE | 1 |
| plasminogen controls inflammation and pathogenesis of influenza virus infections | ORG | 1 |
| plasmapheresis | ORG | 1 |
| plasma vitamin d | PERSON | 1 |
| plasma lipoproteins | ORG | 1 |
| plasma cu | PERSON | 1 |
| plant defensins human | ORG | 1 |
| pituitary aspergillus infection | DISEASE | 1 |
| preterm labor a | DISEASE | 1 |
| primo | ORG | 1 |
| pierulivo enrique | PERSON | 1 |
| pseudomonas aeruginosa lipopolysaccharides | DISEASE | 1 |
| qutayba almerie muhammad daniel kerrigan david | PERSON | 1 |
| quinazoline | CHEMICAL | 1 |
| quarantine | PERSON | 1 |
| pyroptosis | PERSON | 1 |
| pyridinium | CHEMICAL | 1 |
| pulmunary characteristics | PERSON | 1 |
| pulmonary arterial hypertension | DISEASE | 1 |
| pulmonary vascular | PERSON | 1 |
| pulmonary illness | DISEASE | 1 |
| pulmonary | PERSON | 1 |
| pteridines | CHEMICAL | 1 |
| proteinosis | CHEMICAL | 1 |
| prism | DISEASE | 1 |
| protective immunity | ORG | 1 |
| prostatitis | DISEASE | 1 |
| prostatic hyperplasia | DISEASE | 1 |
| prostate | DISEASE | 1 |
| prostaglandin e2 | CHEMICAL | 1 |
| prostaglandin | PERSON | 1 |
| prospect | ORG | 1 |
| properties of coronavirus | ORG | 1 |
| prone | ORG | 1 |
| proinflammatory | LOC | 1 |
| profiling of human testes reveals the presence | ORG | 1 |
| pigliucci | PERSON | 1 |
| pierulivo | CHEMICAL | 1 |
| r01ey030576 | CHEMICAL | 1 |
| px | ORG | 1 |
| paris | GPE | 1 |
| pareek vikas | PERSON | 1 |
| panigada | GPE | 1 |
| panel | ORG | 1 |
| pandemic and pregnancy coronavirus | DISEASE | 1 |
| pandemic coronavirus disease | DISEASE | 1 |
| palermo trapani | PERSON | 1 |
| palermo | GPE | 1 |
| pachetti et al 4 | GPE | 1 |
| pao | ORG | 1 |
| pyd | ORG | 1 |
| ps 57 | ORG | 1 |
| pathogen | ORG | 1 |
| prrs | CHEMICAL | 1 |
| ppp1ca | CHEMICAL | 1 |
| ppe | CHEMICAL | 1 |
| pparalpha | ORG | 1 |
| popc | ORG | 1 |
| pmn tau cl | ORG | 1 |
| pka | ORG | 1 |
| pg dexamethasone | CHEMICAL | 1 |
| pfa | ORG | 1 |
| perspectives | DISEASE | 1 |
| pdb | ORG | 1 |
| parodi aurora cozzani emanuele | PERSON | 1 |
| pathological | GPE | 1 |
| phytotherapeutics | ORG | 1 |
| peyronie s | DISEASE | 1 |
| phytoconstituents | CHEMICAL | 1 |
| photolysis of n | ORG | 1 |
| phosphatidylserine ps | PERSON | 1 |
| phosphatidylglycerol and surfactant a | ORG | 1 |
| phosphatidylglycerol | CHEMICAL | 1 |
| phi6 | PERSON | 1 |
| phase | PERSON | 1 |
| pharmacologic treatments | PERSON | 1 |
| pharmacokinetics of n | ORG | 1 |
| pharma | GPE | 1 |
| phagocytosis | ORG | 1 |
| peter sommerfeld nigel | PERSON | 1 |
| pathways | PERSON | 1 |
| persistence | PERSON | 1 |
| perrin david m | PERSON | 1 |
| perrin | CHEMICAL | 1 |
| peroxisome proliferator activated | ORG | 1 |
| perl et al | PERSON | 1 |
| pentoxifylline pentifylline | CHEMICAL | 1 |
| pentoxifylline ptx | CHEMICAL | 1 |
| peng | PERSON | 1 |
| pedro gonçalves de oliveira | PERSON | 1 |
| paul nisticò | PERSON | 1 |
| patruno cataldo | PERSON | 1 |
| química luar | PERSON | 1 |
| r03ag059554 | CHEMICAL | 1 |
| sars cov 2 spike | ORG | 1 |
| risk | PERSON | 1 |
| rosetti | ORG | 1 |
| roncati luca gallo graziana | PERSON | 1 |
| roncati | DISEASE | 1 |
| romania | GPE | 1 |
| roles | PERSON | 1 |
| role of n | ORG | 1 |
| rohit anusha | ORG | 1 |
| robert a sandhaus | PERSON | 1 |
| robert a chan edward d | PERSON | 1 |
| roberge rj et al | PERSON | 1 |
| risks | GPE | 1 |
| right ventricular dysfunction | DISEASE | 1 |
| rubella virus | TAXON | 1 |
| ribavirin | CHEMICAL | 1 |
| rheumatoid arthritis | DISEASE | 1 |
| rhee 2020 | PERSON | 1 |
| reziya wang | PERSON | 1 |
| results | ORG | 1 |
| respiratory distress syndrome | DISEASE | 1 |
| respiratory virus infections | DISEASE | 1 |
| respiratory viral infections | DISEASE | 1 |
| respiratory syndrome coronavirus sars | DISEASE | 1 |
| respiratory syndrome coronavirus 2 sars | DISEASE | 1 |
| respiratory syndrome mers coronavirus | DISEASE | 1 |
| roxana | PERSON | 1 |
| russia | GPE | 1 |
| respiratory syndrome coronavirus sars | DISEASE | 1 |
| sars cov 2 entry | ORG | 1 |
| sars cov 2 rna | ORG | 1 |
| sars cov 2 patient later | ORG | 1 |
| sars cov 2 national science review genomewide association study of severe covid 19 | ORG | 1 |
| sars cov 2 ma15 | ORG | 1 |
| sars cov 2 infection | DISEASE | 1 |
| sars cov 2 il | ORG | 1 |
| sars cov 2 human cell tropism | ORG | 1 |
| sars cov 2 genetic | ORG | 1 |
| sars cov 2 future | ORG | 1 |
| sars cov 2 experimental | ORG | 1 |
| sars cov 2 epigallocatechin | ORG | 1 |
| sars cov 2 cytokine | ORG | 1 |
| rutkowski 2020 | PERSON | 1 |
| sars cov 2 clinical | ORG | 1 |
| sars cov 2 cell entry | ORG | 1 |
| sars cov 2 cardiovascular considerations for patients health care workers | ORG | 1 |
| sars cov 2 besides | ORG | 1 |
| sars cov 2 background | ORG | 1 |
| sars cov 2 a systematic | ORG | 1 |
| sars cov 19 | ORG | 1 |
| sars cov 17 | ORG | 1 |
| sars cov 2 transmission | ORG | 1 |
| sabre | ORG | 1 |
| s aureus proteins | TAXON | 1 |
| respiratory syndrome mers | DISEASE | 1 |
| respiratory syndrome coronavirus mers | DISEASE | 1 |
| raas | ORG | 1 |
| rorγt | ORG | 1 |
| rare earth | LOC | 1 |
| ranvier | ORG | 1 |
| ranran li | CHEMICAL | 1 |
| ramirez j | PERSON | 1 |
| ramedesivir | GPE | 1 |
| raha syamal mallick | PERSON | 1 |
| radon | ORG | 1 |
| radiologic | GPE | 1 |
| rabbani 2018 | ORG | 1 |
| rt | ORG | 1 |
| rsv infection | DISEASE | 1 |
| rns | ORG | 1 |
| rat hippocampal slices curcumin | ORG | 1 |
| rna sequencing procedures | ORG | 1 |
| rn | ORG | 1 |
| rig | ORG | 1 |
| recovery | ORG | 1 |
| rct adaptive | ORG | 1 |
| raw | ORG | 1 |
| rat1 | PERSON | 1 |
| ras abnormality | DISEASE | 1 |
| ras ace ang ii at1 maintaining | ORG | 1 |
| ras | ORG | 1 |
| rankl | ORG | 1 |
| ras | PERSON | 1 |
| ratio | GPE | 1 |
| respiratory syndrome coronavirus infection | DISEASE | 1 |
| relative humidity | ORG | 1 |
| respiratory coronavirus emc | DISEASE | 1 |
| respiratory 204 syndrome coronavirus 2 sars cov | DISEASE | 1 |
| respir care | PERSON | 1 |
| residency | PERSON | 1 |
| res social | PERSON | 1 |
| renin angiotensin aldosterone system | PERSON | 1 |
| renin | PERSON | 1 |
| remdesivir gilead breakthrough chloroquine | PERSON | 1 |
| remdesivir | PERSON | 1 |
| release | PERSON | 1 |
| relaxation of the community | ORG | 1 |
| related multi | ORG | 1 |
| ratio kidney | PERSON | 1 |
| reimer holmgren | PERSON | 1 |
| reilly niall | PERSON | 1 |
| regensburg | GPE | 1 |
| reducing sugars | PERSON | 1 |
| reducing health care workers absenteeism | ORG | 1 |
| recombination reservoirs | PERSON | 1 |
| rebbapragada | GPE | 1 |
| rdrp | LOC | 1 |
| rb | ORG | 1 |
| rationale | ORG | 1 |
| ratio kidney disease | DISEASE | 1 |
| igg h l highly cross adsorbed secondary antibody | ORG | 1 |
| asthma exacerbations | DISEASE | 1 |
| ibuprofen s | LOC | 1 |
| bioaerosol fate | ORG | 1 |
| cv disease | DISEASE | 1 |
| ctri | ORG | 1 |
| ctl | ORG | 1 |
| css | ORG | 1 |
| crispr | ORG | 1 |
| creb association | ORG | 1 |
| cp | CHEMICAL | 1 |
| covid 19 | ORG | 1 |
| covid 19 renal disease | DISEASE | 1 |
| covid 19 pneumonia date 2020 | ORG | 1 |
| covid 19 mortality trained | ORG | 1 |
| covid 19 date 2020 11 06 | ORG | 1 |
| covid 19 date 2020 05 24 | ORG | 1 |
| covid 19 pathogen recognition | ORG | 1 |
| covid 19 ptx | ORG | 1 |
| covid 19 neuroimmune | ORG | 1 |
| covid 19 mechanistic | ORG | 1 |
| covid 19 infections studies | ORG | 1 |
| covid 19 genetic | ORG | 1 |
| covid 19 garlic | ORG | 1 |
| covid 19 formation | ORG | 1 |
| covid 19 connecting bcg vaccination | ORG | 1 |
| covid 19 concurrent | ORG | 1 |
| covid 19 clinical | ORG | 1 |
| covid 19 building | ORG | 1 |
| cx001357 | CHEMICAL | 1 |
| cyp2b1 | CHEMICAL | 1 |
| cyp2c9 cyp2c19 | CHEMICAL | 1 |
| cancers | DISEASE | 1 |
| carlos g goren andy | PERSON | 1 |
| carelli pasquale | ORG | 1 |
| cardona maya | PERSON | 1 |
| cardiovascular complications | DISEASE | 1 |
| cardiovascular | LOC | 1 |
| cardiotoxic | DISEASE | 1 |
| cardiac injury extrapulmonary manifestations | DISEASE | 1 |
| cardiac injury | DISEASE | 1 |
| cardiac function | ORG | 1 |
| capillarity | DISEASE | 1 |
| candida species albumin | TAXON | 1 |
| cancer types | ORG | 1 |
| cyp3a | ORG | 1 |
| cancer patients implications for dosing within the therapeutic window disease | ORG | 1 |
| camostat | ORG | 1 |
| calorimetric | ORG | 1 |
| calmette guérin bcg | PERSON | 1 |
| calmette guerin bcg | PERSON | 1 |
| calmette guerin | PERSON | 1 |
| california | GPE | 1 |
| caetano silva filho josé | ORG | 1 |
| cyps | TAXON | 1 |
| cyp4a | CHEMICAL | 1 |
| cyp3a11 | CHEMICAL | 1 |
| covid 19 alpha 1 | ORG | 1 |
| covid 19 9 | ORG | 1 |
| covid 19 64 | ORG | 1 |
| breast cancer | DISEASE | 1 |
| c0v | CHEMICAL | 1 |
| c gattii species complexes | TAXON | 1 |
| c c | ORG | 1 |
| bynoe | PERSON | 1 |
| buxco eletronics inc nc usa | ORG | 1 |
| busà l | ORG | 1 |
| burnout prevention | ORG | 1 |
| budesonide or fluticasone | ORG | 1 |
| budesonide | CHEMICAL | 1 |
| brunhilde | GPE | 1 |
| brenner steven | PERSON | 1 |
| brazil dynamics | ORG | 1 |
| c5b | CHEMICAL | 1 |
| bracey dangerfield phd | ORG | 1 |
| bou khalil rami | PERSON | 1 |
| bone marrow derived cells increases expression of tnf α | ORG | 1 |
| bogdan | GPE | 1 |
| bobadilla vanessa kenedy | PERSON | 1 |
| blount | ORG | 1 |
| biswas subrata k mudi sonchita | PERSON | 1 |
| biotech shanghai | PERSON | 1 |
| biological | ORG | 1 |
| bioethics committee | ORG | 1 |
| biochemistry | PERSON | 1 |
| c3a | CHEMICAL | 1 |
| car | ORG | 1 |
| covid 19 23 | ORG | 1 |
| cnpq pronex | PERSON | 1 |
| covid 19 11 | ORG | 1 |
| covid 19 10 | ORG | 1 |
| covid 19 1 | ORG | 1 |
| covi 19 | ORG | 1 |
| covacta | ORG | 1 |
| cov | ORG | 1 |
| coronado | ORG | 1 |
| copd title empiric antibiotics in management of inpatient pregnant women infected with | ORG | 1 |
| cooh | ORG | 1 |
| co poisoning | DISEASE | 1 |
| cns infections | DISEASE | 1 |
| cmv 34 garlic | ORG | 1 |
| ccr5 Δ32 | PERSON | 1 |
| cm | DISEASE | 1 |
| chq zpak zinc | ORG | 1 |
| cfr | ORG | 1 |
| cd4 t cells dendritic cells dc | ORG | 1 |
| cd4 foxp3 treg | ORG | 1 |
| cd4 cd8 | ORG | 1 |
| cd4 cd25 foxp3 tregs | PERSON | 1 |
| cd34 | CHEMICAL | 1 |
| cd33 myeloid | CHEMICAL | 1 |
| cd163 | CHEMICAL | 1 |
| cd14 novel | ORG | 1 |
| carlsbad ca | PERSON | 1 |
| carotid atherosclerosis | ORG | 1 |
| carsana | GPE | 1 |
| colchicine update | ORG | 1 |
| control of the innate immune response | ORG | 1 |
| continuous | LOC | 1 |
| consideration of the aerosol transmission for covid 19 | ORG | 1 |
| conjugated | CHEMICAL | 1 |
| compounds triosidines | PERSON | 1 |
| compounds | ORG | 1 |
| complex lung damage | DISEASE | 1 |
| complement | ORG | 1 |
| comparative | ORG | 1 |
| combat | DISEASE | 1 |
| collide loss of hepatic pparα | CHEMICAL | 1 |
| colchicine | CHEMICAL | 1 |
| converts angiotensin | PERSON | 1 |
| cohen hurtado ziola | PERSON | 1 |
| coenzyme q10 | ORG | 1 |
| coenzyme q not | ORG | 1 |
| coagulation disorders | DISEASE | 1 |
| coagulation and fibrinolysis | LOC | 1 |
| coagulation abnormalities | DISEASE | 1 |
| coagulation | DISEASE | 1 |
| covzc45 | TAXON | 1 |
| coa | ORG | 1 |
| clÞ | DISEASE | 1 |
| clinical features | PERSON | 1 |
| convergence | PERSON | 1 |
| copper cu | PERSON | 1 |
| citrus | TAXON | 1 |
| coronavirus diseases covid | DISEASE | 1 |
| correlation | ORG | 1 |
| coronavirus pandemic covid | DISEASE | 1 |
| coronavirus infections | DISEASE | 1 |
| coronavirus infection | DISEASE | 1 |
| coronavirus induced disease | DISEASE | 1 |
| coronavirus sars cov | DISEASE | 1 |
| coronavirus sars | DISEASE | 1 |
| coronavirus pneumonia precision clinical medicine epidemiologic | ORG | 1 |
| coronavirus pneumonia emergency response epidemiology team | ORG | 1 |
| coronavirus pneumonia emergency response epidemiology | ORG | 1 |
| coronavirus oc43 infection | DISEASE | 1 |